intervention,"Active, not recruiting",Completed,Enrolling by invitation,Recruiting,Terminated,Total
NA,54,141,34,403,1,633
placebo,81,64,14,326,16,501
standard care,15,36,5,105,5,166
hydroxychloroquine,20,30,7,49,16,122
questionnaire,6,34,5,70,1,116
convalescent plasma,16,24,4,65,2,111
no intervention,8,8,2,37,0,55
blood sample,2,4,1,43,1,51
azithromycin,8,9,2,21,3,43
ivermectin,0,19,1,23,0,43
saline,9,3,2,26,0,40
tocilizumab,8,10,0,18,4,40
remdesivir,5,7,0,22,2,36
mesenchymal stem cells,7,5,2,19,0,33
pcr,3,10,2,16,0,31
serology test,2,4,3,22,0,31
favipiravir,6,3,1,18,0,28
ritonavir,3,6,2,15,1,27
prone positioning,3,4,1,18,0,26
lopinavir,3,4,2,14,1,24
enoxaparin,0,0,0,19,1,20
chloroquine,1,4,1,10,3,19
exercise,0,7,1,11,0,19
lopinavir/ritonavir,2,4,2,10,1,19
vitamin d,3,3,2,11,0,19
colchicine,0,3,0,15,0,18
control,2,2,0,12,2,18
heparin,1,2,1,14,0,18
methylprednisolone,2,7,0,9,0,18
vitamin c,2,5,0,10,1,18
nitazoxanide,2,4,0,11,0,17
oxygen,4,1,0,11,1,17
biological samples,1,2,1,12,0,16
dexamethasone,1,2,0,11,2,16
online survey,1,3,3,9,0,16
plasma,0,4,1,11,0,16
saliva,1,2,1,12,0,16
survey,3,6,0,7,0,16
interferon,1,5,1,8,0,15
anakinra,1,2,0,8,3,14
observational,1,3,0,8,1,13
telehealth,1,5,1,6,0,13
hydroxychloroquine / azithromycin,3,5,2,1,1,12
baricitinib,0,2,0,9,0,11
covid-19,1,1,0,8,1,11
lung ultrasound,1,0,1,9,0,11
radiotherapy,2,2,0,7,0,11
bcg,3,0,0,7,0,10
igm/igg rapid test,0,3,2,5,0,10
ruxolitinib,2,1,0,6,1,10
ace inhibitor,1,2,1,5,0,9
camostat mesilate,1,0,0,8,0,9
data collection,1,1,0,7,0,9
zinc,0,3,0,6,0,9
best available therapy,0,3,0,5,0,8
blood test,1,1,0,6,0,8
ct-scan,1,2,0,5,0,8
losartan,0,4,0,4,0,8
nitric oxide,4,1,0,3,0,8
observation,1,2,0,5,0,8
rivaroxaban,1,0,0,7,0,8
cholecalciferol,0,1,0,6,0,7
exposure,1,2,0,4,0,7
nasopharyngeal swab,0,1,0,6,0,7
povidone/iodine,0,4,0,3,0,7
rapid test,2,3,1,1,0,7
sarilumab,1,3,0,2,1,7
serum test,0,2,0,5,0,7
aspirin,0,0,1,5,0,6
igg,0,3,1,2,0,6
igg antibody test,0,2,2,2,0,6
inactivated sars-cov-2 vaccine,2,0,2,2,0,6
interview,1,2,0,3,0,6
ly3819253,0,1,0,5,0,6
mindfulness,0,1,0,5,0,6
oseltamivir,1,0,0,5,0,6
quality-of-life assessment,0,0,0,6,0,6
sofosbuvir,0,2,0,4,0,6
therapeutic plasma exchange (tpe),2,2,0,2,0,6
ad26.cov2.s,3,0,0,2,0,5
adenovirus type 5 vector,3,0,0,2,0,5
arb,1,0,0,4,0,5
azd7442,1,0,0,4,0,5
best supportive care,1,2,0,2,0,5
biospeciman collection,0,0,0,5,0,5
biospecimen collection,0,0,0,5,0,5
bnt162b2,3,0,0,2,0,5
chest ct,0,3,0,2,0,5
chloroquine/hydroxychloroquine,0,0,1,4,0,5
clazakizumab,2,0,1,2,0,5
doxycycline,0,4,0,1,0,5
famotidine,0,2,0,3,0,5
gam-covid-vac,3,1,0,1,0,5
igm,0,0,1,4,0,5
interleukin,1,0,0,4,0,5
lenzilumab,1,0,0,4,0,5
melatonin,1,0,0,4,0,5
nk cells,1,0,0,4,0,5
pulmozyme,0,0,0,5,0,5
regn10933,1,0,0,4,0,5
regn10987,1,0,0,4,0,5
supportive care,2,2,0,1,0,5
telmisartan,0,1,0,4,0,5
ultrasound,0,1,0,4,0,5
,0,2,1,1,0,4
anticoagulation,0,0,0,3,1,4
arbidol,1,1,0,2,0,4
bromhexine hydrochloride,1,1,1,1,0,4
budesonide,1,0,0,2,1,4
ciclesonide,0,0,0,4,0,4
covid-19 pandemic,1,1,0,2,0,4
daclatasvir,0,0,0,4,0,4
data record,0,0,0,4,0,4
education,0,2,1,1,0,4
fluvoxamine,0,1,0,3,0,4
igm antibodytest,0,3,0,1,0,4
immunoglobulin,0,2,0,2,0,4
mask,0,2,0,2,0,4
mavrilimumab,2,0,0,2,0,4
na-831,0,0,2,2,0,4
nafamostat mesilate,0,1,0,3,0,4
nasal rinse,0,0,0,4,0,4
niclosamide,0,0,0,4,0,4
peginterferon,1,0,1,2,0,4
pulmonary rehabilitation,1,1,1,1,0,4
sargramostim,1,0,0,3,0,4
sars-cov-2 rs,1,0,0,3,0,4
spirometry,0,0,1,3,0,4
acalabrutinib,0,2,0,0,1,3
adjuvant,1,0,0,2,0,3
antibody test,0,1,0,2,0,3
ayurveda,0,3,0,0,0,3
bcg-denmark,1,0,0,2,0,3
behavior,1,0,0,2,0,3
behavioral,0,0,2,0,1,3
biological,1,0,0,2,0,3
blood,0,0,0,3,0,3
blood donation sms,0,1,2,0,0,3
bnt162b1,2,0,0,1,0,3
breath test,0,1,0,2,0,3
camostat,0,0,0,3,0,3
canakinumab,1,1,0,1,0,3
cannabidiol,2,0,0,1,0,3
cellectraâ® 2000,1,0,0,2,0,3
cenicriviroc,0,0,0,3,0,3
chadox1,2,0,0,1,0,3
clinical assessment,0,2,0,1,0,3
clinical data,2,0,0,1,0,3
clopidogrel,0,1,0,2,0,3
corticosteroid,0,0,0,3,0,3
coviage,0,3,0,0,0,3
cpap,1,0,0,2,0,3
cyclosporine,0,0,0,3,0,3
cytokine adsorption,0,0,0,3,0,3
cytosorb,0,0,0,3,0,3
dalteparin,0,2,0,1,0,3
defibrotide,0,0,0,3,0,3
ecg,0,0,0,3,0,3
echocardiography,0,2,0,1,0,3
eidd-2801,1,1,0,1,0,3
elisa,1,2,0,0,0,3
emtricitabine,0,0,0,3,0,3
flow cytometry,0,2,0,1,0,3
high flow nasal cannula,0,2,0,1,0,3
infliximab,0,1,0,2,0,3
information,0,0,2,1,0,3
ino-4800,1,0,0,2,0,3
kg,0,1,0,2,0,3
low,1,0,0,2,0,3
ly3832479,0,0,0,3,0,3
mesenchymalÂ stem cells,0,0,0,3,0,3
mri,0,0,0,3,0,3
mrna-1273,2,0,0,1,0,3
n-acetylcysteine,0,0,0,3,0,3
naltrexone,0,0,1,2,0,3
nasal,0,1,0,2,0,3
non-interventional,0,1,0,2,0,3
nutrition,1,0,0,2,0,3
opaganib,1,1,0,1,0,3
other,0,1,0,2,0,3
paracetamol,1,0,0,2,0,3
pcr/serology,0,0,0,3,0,3
phone call,0,0,0,3,0,3
pirfenidone,0,0,0,3,0,3
prednisone,0,1,0,1,1,3
probiotic,0,0,0,3,0,3
quality of life,0,0,1,2,0,3
ravulizumab,1,0,0,2,0,3
regn10933/regn10987 combination therapy,0,0,0,3,0,3
ribavirin,0,1,0,2,0,3
sample collection,0,0,0,3,0,3
sampling,0,0,0,3,0,3
sars-cov-2 rs/matrix-m1 adjuvant,1,0,0,2,0,3
sevoflurane,0,0,0,3,0,3
sodium,0,0,0,3,0,3
suspension of heat killed (autoclaved) mycobacterium w,0,1,0,2,0,3
taste,0,2,0,1,0,3
throat swab,0,1,0,2,0,3
thromboprophylaxis,0,1,0,2,0,3
tinzaparin,0,2,0,1,0,3
tofacitinib,2,1,0,0,0,3
vir-7831,0,0,0,3,0,3
vitamin super b-complex,2,0,0,1,0,3
vpm1002,2,0,0,1,0,3
vv-ecmo,0,1,0,2,0,3
yoga,0,0,0,3,0,3
10 to 14 days later,0,0,0,2,0,2
28-day schedule,0,0,1,1,0,2
300 mg of omega3-fa,0,0,1,1,0,2
99mtc-pertechnetate aerosol,0,0,0,2,0,2
abatacept,0,0,0,2,0,2
acetylsalicylic acid,0,1,0,1,0,2
acute kidney injury,0,1,0,1,0,2
adsorbed covid-19 (inactivated) vaccine,1,0,1,0,0,2
aeonose,0,2,0,0,0,2
allocetra-ots,1,0,0,1,0,2
ampion,0,1,0,1,0,2
antibiotics,0,1,0,1,0,2
antihypertensives,1,0,0,1,0,2
apixaban,0,0,0,2,0,2
appendectomy,0,2,0,0,0,2
apremilast,0,0,0,2,0,2
asbrip,0,1,0,1,0,2
assessment of work-related stress,0,1,0,1,0,2
atazanavir,0,0,0,2,0,2
atorvastatin,0,0,0,2,0,2
av-covid-19,1,0,0,1,0,2
avdoralimab,1,0,0,1,0,2
avigan,1,0,0,1,0,2
azd1222,1,0,0,1,0,2
bacille calmette-guã©rin (bcg),0,0,0,2,0,2
bevacizumab,0,1,0,1,0,2
biological data,2,0,0,0,0,2
blood collection on their first consultation/10 to 14 days later,0,0,0,2,0,2
blood draw,0,0,0,2,0,2
brequinar,0,1,0,1,0,2
cardiac,0,1,0,1,0,2
cardiac/electrodermal recordings,0,1,0,1,0,2
caring contacts,0,0,1,1,0,2
chlorine dioxide,0,0,0,2,0,2
clinical examination,1,0,0,1,0,2
clinical features,0,1,0,1,0,2
cobicistat,0,0,0,2,0,2
conjunctival swab,0,1,0,1,0,2
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)/traditional chinese medicines (tcms) granules",0,0,0,2,0,2
corticosteroids,1,0,0,1,0,2
covid-19 antigen,1,0,0,1,0,2
covid-19 patients,0,0,0,2,0,2
covid-19 vaccine,0,0,0,2,0,2
ct-p59,1,0,0,1,0,2
cvncov vaccine,1,0,0,1,0,2
cyt107,0,0,0,2,0,2
dalargin,0,1,0,1,0,2
dapagliflozin,1,0,0,1,0,2
darunavir,0,0,0,2,0,2
darunavir/cobicistat,0,0,0,2,0,2
diagnostic laboratory biomarker analysis,0,0,0,2,0,2
diagnostic test,0,1,0,1,0,2
dialysis,1,0,0,1,0,2
dipyridamole,1,0,0,1,0,2
distilled water,0,1,0,1,0,2
dornase alfa,0,2,0,0,0,2
dose)- stage 2,0,0,0,2,0,2
dose) - stage 1,0,0,0,2,0,2
dose) - stage 2,0,0,0,2,0,2
doxycycline tablets,0,0,0,2,0,2
duvelisib,0,0,0,2,0,2
edp1815,0,0,0,2,0,2
electrodermal recordings,0,1,0,1,0,2
electronic health record review,0,0,0,2,0,2
emotional stimulation,0,1,0,1,0,2
essential oils,0,1,0,1,0,2
exercise training,0,0,0,2,0,2
exo 1 inhalation,0,1,1,0,0,2
exo 2 inhalation,0,1,1,0,0,2
expressive writing,0,2,0,0,0,2
favipiravir/hydroxychloroquine,1,0,0,1,0,2
file scanning,0,1,0,1,0,2
fit test,0,2,0,0,0,2
fondaparinux,0,2,0,0,0,2
fostamatinib,0,0,0,2,0,2
fuzheng huayu,0,1,0,1,0,2
glycine,0,0,0,2,0,2
guduchi ghan vati,0,2,0,0,0,2
health supplements,0,0,0,2,0,2
high dosage inactivated sars-cov-2 vaccine,2,0,0,0,0,2
high flow nasal cannula (hfnc),0,0,0,2,0,2
honey,0,1,0,1,0,2
hormones,1,0,0,1,0,2
human amniotic fluid,0,0,0,2,0,2
hyperbaric oxygen,0,0,0,1,1,2
hzvsf-v13,0,0,0,2,0,2
ibrutinib,0,0,0,2,0,2
ibuprofen,0,0,0,2,0,2
icu treatment,0,0,0,2,0,2
igg test,0,1,0,1,0,2
iloprost,0,0,0,2,0,2
imatinib,0,0,0,2,0,2
imu-838,0,0,0,2,0,2
indicators of central sensitisation,0,0,0,2,0,2
intramuscular vaccine,1,0,0,1,0,2
iodine,0,0,0,2,0,2
ion mobility spectrometry (ims),0,0,0,2,0,2
iota-carrageenan,0,1,0,1,0,2
kb109,1,0,0,1,0,2
kb109 / self supportive care (ssc),1,0,0,1,0,2
l-citrulline,0,0,0,2,0,2
lanadelumab,0,0,0,2,0,2
ledipasvir,0,2,0,0,0,2
leflunomide,0,0,0,2,0,2
longitudinally,0,0,0,2,0,2
lucira covid-19 all-in-one test kit,0,1,0,1,0,2
lung ultrasound (lus),0,0,0,2,0,2
"magpro x100 stimulator, b70 fluid-cooled coil",0,0,0,2,0,2
maraviroc,0,1,0,1,0,2
mechanical ventilation,1,0,0,1,0,2
meditation,0,0,1,1,0,2
meditation (1 x 20-minute guided audio training),0,0,0,2,0,2
medium dosage inactivated sars-cov-2 vaccine,2,0,0,0,0,2
medium dosage inactivated sars-cov-2 vaccine on a 0-,0,0,1,1,0,2
medium dosage inactivated sars-cov-2 vaccine on a 0-/28-day schedule,0,0,1,1,0,2
mefloquine,0,2,0,0,0,2
menacwy,1,0,0,1,0,2
methylene blue,0,0,0,2,0,2
molnupiravir,0,0,0,2,0,2
muscle,1,0,0,1,0,2
nasopharyngeal,0,1,0,1,0,2
nasopharyngeal swabs,0,0,0,2,0,2
news,0,1,0,0,1,2
nigella sativa,0,1,0,1,0,2
normal saline (0.9% sodium chloride solution)- stage 2,0,0,0,2,0,2
normal saline (0.9% sodium chloride solution) - stage 1,0,0,0,2,0,2
octagam,2,0,0,0,0,2
omega-3,0,0,0,2,0,2
online questionnaires,0,1,0,1,0,2
online support group,1,1,0,0,0,2
ophthalmologic exam,0,1,0,1,0,2
oral polio vaccine,0,0,2,0,0,2
physical therapy,1,0,0,1,0,2
physiotherapy,0,2,0,0,0,2
placebo (normal saline solution),0,0,0,2,0,2
plx-pad,0,0,0,2,0,2
povidone-iodine,0,0,0,2,0,2
practice details,0,2,0,0,0,2
prayer,0,0,0,2,0,2
pregnant women with laboratory-confirmed 2019-n-cov,0,0,0,2,0,2
preventive information,0,0,2,0,0,2
psychological,1,0,0,1,0,2
pul-042,0,0,0,2,0,2
pulmonary function tests,0,0,0,2,0,2
pyronaridine-artesunate,0,0,0,2,0,2
quercetin,0,1,0,1,0,2
radiological,0,0,0,2,0,2
rapid diagnostic test vs pcr,0,0,0,2,0,2
recombinant new coronavirus vaccine (cho cell) low-dose group,2,0,0,0,0,2
recombinant new coronavirus vaccine (cho cells) high-dose group,2,0,0,0,0,2
recop unit patient,1,1,0,0,0,2
regn10933 / regn10987,1,0,0,1,0,2
rehabilitation,0,1,0,1,0,2
rivaroxaban 10 mg,0,0,0,2,0,2
rtb101,1,0,0,0,1,2
ruconest,0,0,0,2,0,2
sars-cov-2,0,1,0,1,0,2
sars-cov2 infection,1,0,0,1,0,2
self supportive care (ssc),1,0,0,1,0,2
self supportive care (ssc) alone,1,0,0,1,0,2
selinexor,0,1,0,1,0,2
semi-directive interview,0,0,0,2,0,2
silmitasertib,0,0,0,2,0,2
siltuximab,1,0,0,1,0,2
simple cognitive task intervention,0,0,0,2,0,2
sirolimus,0,0,0,2,0,2
sivomixx,1,0,0,1,0,2
sng001,0,0,0,2,0,2
soc / placebo,0,1,0,1,0,2
sodium bicarbonate,1,0,0,1,0,2
sofosbuvir/daclatasvir,0,0,0,2,0,2
sofosbuvir/ledipasvir,0,2,0,0,0,2
standard covid-19 care,0,0,0,2,0,2
stool collection,0,1,0,1,0,2
swab,0,0,0,2,0,2
tacrolimus,0,0,0,2,0,2
td-0903,0,1,0,1,0,2
tele-yoga,0,2,0,0,0,2
tenofovir disoproxil,0,0,0,2,0,2
thymalfasin,0,0,0,2,0,2
tinzaparin/dalteparin,0,2,0,0,0,2
traditional chinese medicine,0,0,0,2,0,2
"two doses of low dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,0,1,0,2
"two doses of medium dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,0,1,0,2
ty027,1,0,0,1,0,2
ultrasonography,0,1,0,1,0,2
uvc irradiation,0,2,0,0,0,2
vehicle control,0,0,0,2,0,2
viusid,0,1,0,1,0,2
volatile organic compounds analysis,0,0,0,2,0,2
vv-ecmo / cytokine adsorption,0,0,0,2,0,2
water,0,1,0,0,1,2
whole exome sequencing,0,0,0,2,0,2
- tocilizumab,0,1,0,0,0,1
-interferon nebulization,0,1,0,0,0,1
"""calm"" is a mindfulness meditation mobile app",0,1,0,0,0,1
"""sham""-block with placebo (isotone nacl)",0,0,0,1,0,1
),0,0,1,0,0,1
": igg, ig m serologies in the amniotoc fluid, the blood cord",0,0,0,1,0,1
[68ga]ga-dota-(rgd)2 pet,0,0,0,1,0,1
[68ga]ga-dota-(rgd)2 pet/ct,0,0,0,1,0,1
[timp-2]*[igfbp-7],0,1,0,0,0,1
0.07% cetylpyridinium chloride (cpc) in mouthwash,0,0,0,1,0,1
0.075% cetylpyridinium chloride,0,0,0,1,0,1
0.075% cetylpyridinium chloride (cpc),0,0,0,1,0,1
0.1% sodium hypochlorite,0,0,0,1,0,1
0.12% chg oral rinse,0,0,0,1,0,1
0.12% chlorhexidine gluconate,0,0,0,1,0,1
0.12% chlorhexidine gluconate mouth rinse,0,0,0,1,0,1
0.4ml inj syringe 0.4ml,0,0,0,1,0,1
0.5% povidone iodine,0,0,0,1,0,1
0.5ml,0,0,0,1,0,1
0.9% (w,1,0,0,0,0,1
0.9% (w/v) saline,1,0,0,0,0,1
0.9% normal saline,0,0,0,1,0,1
1 âµg cov2 sam (lnp),0,0,0,1,0,1
1% hydrogen peroxide,0,0,0,1,0,1
1% povidone iodine (pvp-i),0,0,0,1,0,1
1% w,0,0,0,1,0,1
1% w/v povidone-iodide,0,0,0,1,0,1
1.5-2% w,0,0,0,1,0,1
1.5-2% w/v hydrogen peroxide,0,0,0,1,0,1
1.5% hydrogen peroxide (h2o2),0,0,0,1,0,1
10 âµg cov2 sam (lnp),0,0,0,1,0,1
100 mg,0,0,0,1,0,1
1200 mg),1,0,0,0,0,1
14-day schedule,0,0,0,1,0,1
15mg,0,0,0,1,0,1
1600 mg),1,0,0,0,0,1
18f-î±vî²6-bp,0,0,1,0,0,1
2 post-mortem transcutaneous lung biopsies (1 anterior ; 1 posterior) using anatomical landmarks,0,0,0,1,0,1
2.2x10^10vp (qpcr) boost,0,0,0,1,0,1
21 - phase 2,1,0,0,0,0,1
21% ethanol,0,0,0,1,0,1
21% ethanol/essential oils,0,0,0,1,0,1
24 hour holter ecg,0,0,0,1,0,1
24h transdermal patch - 24 hour,0,0,0,1,0,1
25 post icu-patients,0,0,0,1,0,1
25 post non-icu patients,0,0,0,1,0,1
28),0,0,0,1,0,1
3 âµg cov2 sam (lnp),0,0,0,1,0,1
3),0,0,0,0,1,1
30 âµg cov2 sam (lnp),0,0,0,1,0,1
40-steps-test,0,0,0,1,0,1
400 mg,0,0,0,1,0,1
40ml blood sample,0,0,1,0,0,1
4plants,0,0,1,0,0,1
4plants/azythromycin,0,0,1,0,0,1
5-ala-phosphate,0,0,0,1,0,1
5-ala-phosphate / sfc (5-ala / sfc),0,0,0,1,0,1
5% glucose,1,0,0,0,0,1
6 minute walk test,0,0,1,0,0,1
6 minutes walk test,0,0,0,1,0,1
6 months later,0,0,0,1,0,1
6 weeks after delivery,0,1,0,0,0,1
600mg) oral suspension,0,0,0,1,0,1
99mtc-pertechnetate,0,0,0,1,0,1
a $10 survey incentive,1,0,0,0,0,1
a $20 survey incentive,1,0,0,0,0,1
a short video intervention,0,0,0,1,0,1
a vignette intervention,0,0,0,1,0,1
"ä±t will be compared pain, sleep, fatigue, physical activity level",0,0,1,0,0,1
"ä±t will be compared pain, sleep, fatigue, physical activity level/quality of life/questioning exercise habits before/after the covid-19 outbreak in patients with behã§et/fmf.",0,0,1,0,0,1
aã§aã­ palm berry extract - natural product,0,0,0,1,0,1
aapc,0,0,0,1,0,1
aaz covid-19 rapid test,0,1,0,0,0,1
abbv-47d11,0,0,0,1,0,1
abdominal ultrasound,0,1,0,0,0,1
abivertinib,0,0,0,1,0,1
abpm,0,0,0,1,0,1
abx464,0,0,0,1,0,1
accuchek inform ii platform,0,0,0,1,0,1
"ace inhibitor, angiotensin receptor blocker",0,0,0,1,0,1
ace inhibitor/arb,1,0,0,0,0,1
ace inhibitors/calcium channel blockers,0,1,0,0,0,1
ace/arb,0,0,0,1,0,1
acknowledgement racial injustice ama,1,0,0,0,0,1
actigraphy,0,0,0,1,0,1
action (tara),0,1,0,0,0,1
activase,0,0,0,1,0,1
active comparator,0,0,0,1,0,1
active control:healthy living,1,0,0,0,0,1
active covid-19 disease,0,0,0,1,0,1
activity,0,1,0,0,0,1
ad5-ncov,1,0,0,0,0,1
adam sensor,0,0,0,1,0,1
adaptation at work score (psas),0,1,0,0,0,1
"adaptive immune response, complement activation,",0,0,0,1,0,1
adcld-cov19,0,0,0,1,0,1
adenovirus type-5 vectored covid-19 vaccine,1,0,0,0,0,1
adimrsc-2f,0,0,0,1,0,1
adjunctive therapies,1,0,0,0,0,1
adm03820,0,0,0,1,0,1
administration of equine immunoglobulin anti sars-cov-2,1,0,0,0,0,1
admission to icu for covid-19,0,1,0,0,0,1
aerobic exercises,0,0,1,0,0,1
aerobic training,0,0,0,1,0,1
aerosol box,0,1,0,0,0,1
aerosolized dnase,0,0,0,1,0,1
african american sender acknowledgement,1,0,0,0,0,1
african american sender in informational videos.,1,0,0,0,0,1
after-each-case room disinfection,0,1,0,0,0,1
after covid-19 pandemic,0,0,0,1,0,1
after the covid-19 outbreak in patients with behã§et,0,0,1,0,0,1
ag0301-covid19,1,0,0,0,0,1
ag0302-covid19,1,0,0,0,0,1
agent-797,0,0,0,1,0,1
ai algorithm,0,0,0,1,0,1
ai model,1,0,0,0,0,1
airwave oscillometry,0,0,0,1,0,1
airway management during sedation,0,0,0,1,0,1
airway management during sedation/general anesthesia,0,0,0,1,0,1
airway pressure release ventilation,0,1,0,0,0,1
ak119,0,0,0,1,0,1
alanine,0,0,0,1,0,1
albumine,0,1,0,0,0,1
alcohol mouthwash (listerine) (d) mouth rinse with the solution provided,0,0,0,1,0,1
aldesleukin,0,0,0,1,0,1
alexa amazon,0,0,0,1,0,1
all treatment about covid-2019,0,0,0,1,0,1
allogeneic,1,0,0,0,0,1
allogeneic mesenchymal stem cell,0,1,0,0,0,1
almitrine,0,0,0,1,0,1
"alpha-interferon alpha, abidol, ribavirin, buzhong yiqi plus",1,0,0,0,0,1
"alpha-interferon alpha, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste, fumigation/inhalation of vitamin c",1,0,0,0,0,1
"alpha-interferon, abidol, ribavirin, buzhong yiqi plus",1,0,0,0,0,1
"alpha-interferon, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste/5% glucose",1,0,0,0,0,1
"alpha-interferon, abidol, ribavirin, buzhong yiqi plus/minus formula, huhuang detoxicity paste, baimu qingre jiedu paste/high-dose vitamin c treatment",1,0,0,0,0,1
alpha one antitrypsin,0,0,0,1,0,1
alteplase,0,0,0,1,0,1
alternate nostril breathing,0,1,0,0,0,1
alum adjuvant,1,0,0,0,0,1
aluminum adjuvant of inactivated sars-cov-2 vaccine,1,0,0,0,0,1
alvelestat,0,0,0,1,0,1
alveolar,0,0,0,1,0,1
ama acknowledgement drug pricing,1,0,0,0,0,1
ambrisentan,0,0,0,1,0,1
ambulation,0,0,0,1,0,1
amh sampling,0,0,0,1,0,1
amiodarone,0,0,0,1,0,1
amlodipine,0,0,0,1,0,1
an69-oxiris,0,0,0,1,0,1
an69-standard,0,0,0,1,0,1
anakinra/osoc,0,0,0,0,1,1
anakinra/ruxolitinib,0,0,0,0,1,1
analog scale,0,0,0,1,0,1
analysis of blood samples,0,0,0,1,0,1
"analysis of cytokine response, innate",0,0,0,1,0,1
"analysis of cytokine response, innate/adaptive immune response, complement activation,/serum neurofilaments as a marker of neurological damage.",0,0,0,1,0,1
anesthesia management,0,1,0,0,0,1
ang-3777,0,0,0,1,0,1
anger message,0,1,0,0,0,1
angiogenic biomarkers,0,0,0,1,0,1
angiography scanner,0,0,0,1,0,1
angiotensin,0,0,0,1,0,1
angiotensin-(1-7),0,0,0,1,0,1
angiotensin-converting enzyme inhibitors (ace-i)/angiotensin ii receptor blockers (arb),0,1,0,0,0,1
angiotensin ii,0,0,0,1,0,1
angiotensin ii receptor blockers,0,0,0,1,0,1
angiotensin peptide (1-7) derived plasma,0,0,0,1,0,1
anise,0,0,0,1,0,1
anluohuaxian,0,0,0,1,0,1
anne one,0,0,1,0,0,1
anti-coronavirus antibodies (immunoglobulins)obtained with dfpp from convalescent patients,0,0,0,1,0,1
anti-covid test,1,0,0,0,0,1
anti-sars-cov-2 igt seropositivity,0,1,0,0,0,1
anti-sars-cov-2 igy,0,1,0,0,0,1
anti-sars-cov2 serological controls,0,0,0,1,0,1
anti-sars-cov2 serological controls/serum neutralization,0,0,0,1,0,1
antibiotic,1,0,0,0,0,1
"antibody tests,",1,0,0,0,0,1
anticoagulation agents (edoxaban and,0,0,0,1,0,1
anticoagulation agents (edoxaban and/or high dose lmwh),0,0,0,1,0,1
antidiabetic treatment,0,1,0,0,0,1
antioxidants,0,0,0,1,0,1
antirheumatic drugs,0,0,1,0,0,1
antithrombin,0,1,0,0,0,1
antithrombin / best available treatment,0,1,0,0,0,1
antithrombin iii,0,0,0,1,0,1
antithrombotic therapy (anticoagulant and,0,1,0,0,0,1
antithrombotic therapy (anticoagulant and/or antiplatelet) before admission for covid19,0,1,0,0,0,1
antroquinonol,0,0,0,1,0,1
anxiety,0,0,0,1,0,1
anxiety questionnaire,0,0,0,1,0,1
anxiety reduction training,0,0,0,1,0,1
anxiety),0,0,0,1,0,1
any drug used to treat covid-19,0,0,0,1,0,1
apilimod dimesylate,0,0,0,1,0,1
apixaban 2.5 mg,0,0,0,1,0,1
apixaban 5mg,0,0,0,1,0,1
apl-9,0,0,0,1,0,1
apple watch,0,0,0,1,0,1
apps,0,0,0,1,0,1
apremilast placebo,0,0,0,1,0,1
aprepitant injectable emulsion,0,0,0,1,0,1
aprotinin,1,0,0,0,0,1
arb blocker,0,1,0,0,0,1
arbidol hydrochloride/interferon atomization,0,0,0,1,0,1
arbox,0,0,0,0,1,1
arct-021 dose 1,0,0,0,1,0,1
arct-021 dose 2,0,0,0,1,0,1
arct-021 dose 3,0,0,0,1,0,1
arct-021 dose 4,0,0,0,1,0,1
arct-021 dose regimen 1,0,0,0,1,0,1
arct-021 dose regimen 2,0,0,0,1,0,1
arct-021 single dose priming,0,0,0,1,0,1
arct-021 two higher dose priming,0,0,0,1,0,1
arct-021 two lower dose priming,0,0,0,1,0,1
ards,0,1,0,0,0,1
ards/covid19 treatments,0,1,0,0,0,1
ardsnet,0,0,0,1,0,1
argatroban,0,0,0,1,0,1
art,0,0,0,1,0,1
artemesia annua,0,0,0,1,0,1
artemic,0,0,0,1,0,1
artemisia annua leaf,0,0,0,1,0,1
arterial blood gas,0,0,0,1,0,1
artesunate,0,0,0,1,0,1
artesunate-amodiaquine,0,0,0,1,0,1
asc09,0,0,0,1,0,1
asc09f/oseltamivir,0,0,0,1,0,1
ascorbic acid/zinc gluconate,0,1,0,0,0,1
ashmolean website,0,0,0,1,0,1
asp,0,0,0,1,0,1
aspirin 25mg orally,0,0,0,1,0,1
assembled mask,0,0,0,1,0,1
"assessing antibody responses, neutralizing capacity",1,0,0,0,0,1
"assessing antibody responses, neutralizing capacity/memory b-cell function",1,0,0,0,0,1
assessing impact of covid19,0,0,1,0,0,1
assessment of cardiovascular diseases,0,0,0,1,0,1
assessment of cardiovascular diseases/cardiovascular risk factors,0,0,0,1,0,1
assessment of postnatal depression using the the edinburgh questionnaire between 4,0,1,0,0,0,1
assessment of postnatal depression using the the edinburgh questionnaire between 4/6 weeks after delivery,0,1,0,0,0,1
assessment of the sequelae after hospitalization for sars-cov-2,0,0,1,0,0,1
assessment of ventilator-associated pneumonia criteria,0,0,0,1,0,1
assessment tests,0,0,0,1,0,1
assessment),0,1,0,0,0,1
assigned strategies: active choice,0,0,0,1,0,1
assigned strategies: enhanced active choice,0,0,0,1,0,1
assigned strategies: opt-in,0,0,0,1,0,1
asunercept,0,0,0,1,0,1
asunercept 100mg,0,0,0,1,0,1
asunercept 25mg,0,0,0,1,0,1
asunercept 400mg,0,0,0,1,0,1
asynchronies detection,0,1,0,0,0,1
at-001,0,0,0,1,0,1
at-527,0,0,0,1,0,1
at risk for covid-19 infection,1,0,0,0,0,1
atazanavir/dexamethasone,0,0,0,1,0,1
ati-450,0,0,0,1,0,1
atorvastatin 20 mg oral tablet,0,0,0,1,0,1
atovaquone,0,0,0,1,0,1
atovaquone/azithromycin,0,0,0,1,0,1
attendance by ambulance crew,0,0,0,1,0,1
attention bias modification (abm),0,1,0,0,0,1
atyr1923,0,1,0,0,0,1
audio-visual triage system (avt),0,1,0,0,0,1
audio for relaxation techniques,0,0,0,1,0,1
auditory evoked potentials (aep),0,0,0,1,0,1
augmented message,0,0,0,1,0,1
auricular neuromodulation,0,0,0,1,0,1
auricular percutaneous neurostimulation,0,0,0,1,0,1
auricular stimulation,0,0,0,1,0,1
auscul-x,0,0,0,1,0,1
autologous activated platelet-rich plasma,0,0,0,1,0,1
autologous non-hematopoietic peripheral blood stem cells (nhpbsc),0,1,0,0,0,1
autophagy inhibitor (gns651),0,0,0,1,0,1
autopsy,0,1,0,0,0,1
auxora,0,0,0,1,0,1
aviptadil,1,0,0,0,0,1
aviptadil/standard care,1,0,0,0,0,1
award,0,0,0,1,0,1
award advice,0,0,0,1,0,1
award/covid-specific advice,0,0,0,1,0,1
axillary sweat sample,0,0,0,1,0,1
ayurvedic kadha,0,1,0,0,0,1
azd1656,0,0,0,1,0,1
azithromycin / ivermectin / ribaroxaban / paracetamol,0,0,0,1,0,1
azithromycin / ribaroxaban / paracetamol,0,0,0,1,0,1
azoximer bromide,1,0,0,0,0,1
b: placebo,0,0,0,1,0,1
bactek-r,0,0,0,1,0,1
bactrl-spike,0,0,0,1,0,1
bamlanivimab,0,0,1,0,0,1
bandebereho fathers',0,0,1,0,0,1
bardoxolone methyl,0,0,0,1,0,1
bariatric procedures,0,0,0,1,0,1
baricitinib/anakinra,0,0,0,1,0,1
baseline,0,0,0,1,0,1
baseline blood sample,0,0,0,1,0,1
baseline message,0,1,0,0,0,1
baseline spirometry,0,0,0,1,0,1
baseline/during hospitalization blood samples,0,0,0,1,0,1
basic feedback,1,0,0,0,0,1
bat,0,0,0,1,0,1
bat / calcifediol,0,0,0,1,0,1
bbv152,0,0,0,1,0,1
bbv152a - phase i,1,0,0,0,0,1
bbv152a - phase ii,1,0,0,0,0,1
bbv152b - phase i,1,0,0,0,0,1
bbv152b - phase ii,1,0,0,0,0,1
bbv152c - phase i,1,0,0,0,0,1
bcg-10 vaccine,0,0,0,1,0,1
bd lyotubes,0,0,0,1,0,1
bdb-001 injection,0,0,0,1,0,1
beck depression inventory (bdi),0,1,0,0,0,1
behavioral activation ssi,1,0,0,0,0,1
behavioral/cognitive assessment,0,0,1,0,0,1
behaviour change technique intervention to improve quality of life,0,0,0,1,0,1
bemiparin,0,0,0,1,0,1
bemiparin sodium,0,0,0,1,0,1
bempegaldesleukin,0,0,0,1,0,1
berberine,0,1,0,0,0,1
best message,0,0,0,1,0,1
best message / augmented message/implementation strategy,0,0,0,1,0,1
best message alone,0,0,0,1,0,1
best symptomatic treatment based on doctor recommendations),0,0,0,1,0,1
beta interferon,0,0,0,1,0,1
betadine (c) mouth rinse with the solution provided,0,0,0,1,0,1
betadineâ© bucal 100 mg,0,1,0,0,0,1
betadineâ© bucal 100 mg/ml,0,1,0,0,0,1
bgb dxp593,0,0,0,1,0,1
bi 764198,0,0,0,1,0,1
bicalutamide 150 mg,0,0,0,1,0,1
bicalutamide 150 mg oral tablet,0,0,0,1,0,1
bidirectional oxygenation mouthpiece,0,0,0,1,0,1
big five inventory (bfi) scale,0,0,0,1,0,1
bio 300 oral suspension,0,0,0,1,0,1
bio101,0,0,0,1,0,1
bioargininaâ®,0,0,0,1,0,1
biobehavioral tele-rehabilitation sessions,0,0,0,1,0,1
biochemical analysis,0,1,0,0,0,1
biocollection,0,0,0,1,0,1
biological assays in particular on the lipid metabolism,0,1,0,0,0,1
biological sample/clinical data collection,0,0,0,1,0,1
biological test,0,0,0,1,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,1,0,0,0,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,1,0,0,0,0,1
biological/vaccine: recombinant new coronavirus vaccine (cho cells) placebo group,1,0,0,0,0,1
biological: mrna-1273,1,0,0,0,0,1
"biomarker (tropt, myoglobin, ck, ck-mb, ldh, d-dimer, crp, pct)",0,0,0,1,0,1
biomarkers expression,0,0,0,1,0,1
biomarkers of inflammation,0,0,0,1,0,1
biosensor,0,0,0,1,0,1
biovitals,0,0,0,1,0,1
bivalirudin,0,0,0,1,0,1
bld-2660,1,0,0,0,0,1
blink,0,0,0,1,0,1
blink/masseter inhibitory reflex,0,0,0,1,0,1
"blood collection at day 8, day 16, day 24, month 6",0,0,0,1,0,1
"blood collection at day 8, day 16, day 24, month 6/month 12 after first symptoms from sars-cov-2 infection",0,0,0,1,0,1
blood d-dimer assay,0,1,0,0,0,1
blood group determination,0,0,0,1,0,1
blood sample/data record,0,0,0,1,0,1
blood sampling (venesection),0,0,0,1,0,1
blood test for sars-cov2 serology,0,0,0,1,0,1
"blood tests sputum, nasal lavage",0,0,0,1,0,1
"blood tests sputum, nasal lavage/brushing",0,0,0,1,0,1
blood/derivatives,0,0,0,1,0,1
bloodwork,0,0,0,1,0,1
bms-986253,0,0,0,1,0,1
bnt162a1,0,0,0,1,0,1
bnt162b2 mrna covid-19 vaccine,0,0,0,1,0,1
bnt162b3,0,0,0,1,0,1
bnt162c2,0,0,0,1,0,1
body position change,0,0,0,1,0,1
boost,0,0,0,1,0,1
bovhyaluronidase azoxymer,0,0,0,1,0,1
bovine plasma-derived immunoglobulin concentrate,0,0,0,1,0,1
brain mri,0,0,0,1,0,1
brazilian green propolis extract (epp-af),0,1,0,0,0,1
breath biopsy,0,0,0,1,0,1
breath biopsy face masks with removable filters,0,0,0,1,0,1
breath biopsy face masks with removable filters/fitted pva strip,0,0,0,1,0,1
breath test/cheek swab,0,1,0,0,0,1
"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation",0,0,0,1,0,1
"breathing exercise, intensive spirometry use, supported cough, progressive mobilisation/ambulation",0,0,0,1,0,1
brexanolone,0,0,0,1,0,1
bridge therapy,0,0,0,1,0,1
brief cope scale,0,0,0,1,0,1
brief counseling,0,0,0,1,0,1
brief informational infographic,0,1,0,0,0,1
brief interpersonal telepsychotherapy,0,0,1,0,0,1
brief mindfulness based intervention,0,1,0,0,0,1
brief psychiatric rating scale,0,0,0,1,0,1
brief skills for safer living,0,0,0,1,0,1
brii-196,0,0,0,1,0,1
brii-196/brii-198,0,0,0,1,0,1
brii-198,0,0,0,1,0,1
bromelain,0,0,0,1,0,1
bromhexine 8 mg placebo,0,0,1,0,0,1
bromhexine oral tablet and/or hydroxychloroquine tablet,0,0,0,1,0,1
broncho-vaxomâ®,0,0,0,1,0,1
brushing,0,0,0,1,0,1
btl-tml-covid,0,0,0,1,0,1
bucillamine,0,0,1,0,0,1
building of the classification model,0,0,0,1,0,1
burnout,0,0,0,1,0,1
butterfly,0,0,0,1,0,1
butterfly iq,0,0,0,1,0,1
bva-100,0,0,0,1,0,1
by computer consultation,0,1,0,0,0,1
c-135-ls,0,0,0,1,0,1
c-reactive protein,0,0,0,1,0,1
c144-ls,0,0,0,1,0,1
c144-ls/c-135-ls,0,0,0,1,0,1
c21,0,1,0,0,0,1
c3,0,1,0,0,0,1
c3/ holter monitor,0,1,0,0,0,1
cag,0,0,0,1,0,1
calcifediol,0,0,0,1,0,1
calcium channel blockers,0,1,0,0,0,1
cambridge validated viral detection,0,0,0,1,0,1
camostat mesylate,0,0,0,1,0,1
candesartan,0,0,0,1,0,1
canine odor detection of volatile organic compounds,0,0,0,1,0,1
cap-1002,0,0,0,1,0,1
capillary collection,0,0,0,1,0,1
capillary collection/testing,0,0,0,1,0,1
capnography,0,0,0,1,0,1
cardiac ct,0,0,0,1,0,1
cardiac mri,0,0,0,1,0,1
cardiac surgery,0,0,0,1,0,1
cardiology clinical consultations,0,0,0,1,0,1
cardiopulmonary exercise test,0,0,0,1,0,1
cardiopulmonary resuscitation,0,1,0,0,0,1
cardiovascular magnetic resonance (cmr) imaging,0,0,0,1,0,1
cardiovascular risk factors,0,0,0,1,0,1
care as usual,0,0,1,0,0,1
care modalities,0,1,0,0,0,1
caring contacts without an introductory phone call (cc),0,0,1,0,0,1
caring contacts/introductory phone call (cc/),0,0,1,0,0,1
carotid artery reactivity testing,1,0,0,0,0,1
case fatality rate,0,1,0,0,0,1
cash transfer,1,0,0,0,0,1
castem,0,0,0,1,0,1
cbd isolate,0,0,0,1,0,1
ccp,0,0,0,1,0,1
cd24fc,0,1,0,0,0,1
cefditoren pivoxil 400mg,0,0,0,1,0,1
cell therapy protocol 1,0,0,0,1,0,1
cell therapy protocol 2,0,0,0,1,0,1
cellular immunity,0,0,1,0,0,1
cellular response,0,1,0,0,0,1
centricyte 1000,0,0,0,1,0,1
cerc-002,0,0,0,1,0,1
cerebral compliance,0,1,0,0,0,1
cerebral compliance/hemodynamics monitoring,0,1,0,0,0,1
certified cloth face mask,0,0,1,0,0,1
certified cloth face mask/preventive information,0,0,1,0,0,1
chadox1 ncov-19 single dose,0,0,0,1,0,1
chadox1 ncov-19 single dose / paracetamol,0,0,0,1,0,1
chadox1 ncov-19 two dose,0,0,0,1,0,1
chadox1 ncov-19 two dose / paracetamol,0,0,0,1,0,1
"change in knowledge, motivation, skills, resources",0,0,0,1,0,1
change in preference to surgery under covid-19 pandemic.,0,1,0,0,0,1
chart review,0,0,0,1,0,1
chat-based instant messaging support,1,0,0,0,0,1
chat-based support,0,0,0,1,0,1
cheek swab,0,1,0,0,0,1
chemokines profiles of patients with dexmedetomidine administration,0,0,0,1,0,1
chemotherapy,1,0,0,0,0,1
chest computed tomography,0,0,0,1,0,1
chest ct scan / baseline spirometry,0,0,0,1,0,1
chest mri,0,0,0,1,0,1
chest physiotherapy post-covid19,0,0,0,1,0,1
chest radiography,0,0,1,0,0,1
chest x-ray,0,0,0,1,0,1
chiropractic care (more than one visit),0,1,0,0,0,1
chiropractic care (one visit),0,1,0,0,0,1
chitotriosidase activity,0,0,0,1,0,1
chlorhexidine,0,0,0,1,0,1
chlorhexidine gluconate (a) mouth rinse with the solution provided,0,0,0,1,0,1
choice of assignment: active choice,0,0,0,1,0,1
choice of assignment: enhanced active choice,0,0,0,1,0,1
choice of assignment: opt-in,0,0,0,1,0,1
chx0.12,0,1,0,0,0,1
chx0.12/cpc0.05 oral rinse (perioaidactive control),0,1,0,0,0,1
cig axial,1,0,0,0,0,1
cig tilted,1,0,0,0,0,1
citrox,0,1,0,0,0,1
ck0802,0,0,0,1,0,1
clarithromycin,0,1,0,0,0,1
clarithromycin 500mg,0,1,0,0,0,1
clevudine,0,0,0,1,0,1
clinical data collection,0,0,0,1,0,1
clinical diagnosis of covid-19 by a health care professional,0,0,0,1,0,1
clinical features/laboratory values,0,1,0,0,0,1
clinical interview,0,0,0,1,0,1
clinical observation,0,0,0,1,0,1
clinical outcomes in elderly patients with covid-19.,0,0,0,1,0,1
clinical testing of subjects,1,0,0,0,0,1
"clinical, functional",0,0,0,1,0,1
"clinical, functional/radiological lung involvement evolution",0,0,0,1,0,1
"clinical, laboratory",0,0,0,1,0,1
"clinical, laboratory/imaging characteristics of pneumonia",0,0,0,1,0,1
clinico-biological parameters in routine care,0,0,0,1,0,1
cliniporator,0,0,0,1,0,1
clofazimine,0,0,0,1,0,1
clorhexidine dental phbâ©,0,1,0,0,0,1
closed-loop control of oxygen supplementation by o2matic,0,1,0,0,0,1
clungene rapid test cassette,0,0,0,1,0,1
cns magnetic resonance imaging (mri) imaging,0,0,0,1,0,1
cod liver oil,0,0,0,1,0,1
cognitive,0,0,0,1,0,1
cognitive activity,0,0,0,1,0,1
cognitive assessment,0,0,1,0,0,1
"cognitive behavior therapy (cbt), specifically using the facing your fears (fyf) curriculum",0,0,0,1,0,1
cognitive behavioral brief-telepsychotherapy,0,0,1,0,0,1
cognitive testing,0,0,0,1,0,1
colchicine 0.6 mg,0,0,1,0,0,1
colchicine pill,0,0,0,1,0,1
colchicine/herbal phenolic monoterpene fractions,0,0,0,1,0,1
colchicine/symptomatic treatment (paracetamol),0,0,0,1,0,1
colgate periogard mouthwash,0,0,1,0,0,1
colgate peroxyl mouthwash,0,0,1,0,0,1
colgate total mouthwash,0,0,1,0,0,1
collagen-polyvinylpyrrolidone,0,0,0,1,0,1
"collection of blood, salivary",0,0,0,1,0,1
"collection of blood, salivary/nasopharyngeal samples.",0,0,0,1,0,1
collection of breath sample,0,0,0,1,0,1
collection of mucosal lining fluid,0,1,0,0,0,1
collection of odour samples,0,0,0,1,0,1
collection of swabs,0,0,0,1,0,1
colorectal resections,1,0,0,0,0,1
combination,0,1,0,0,0,1
combined art,0,0,0,1,0,1
combined art/hydroxychloroquine,0,0,0,1,0,1
communication type,0,1,0,0,0,1
"community-based, mobile van testing",0,0,1,0,0,1
community-driven messages to promote covid-19 testing,0,0,1,0,0,1
community health worker support,0,0,1,0,0,1
community health workers.,1,0,0,0,0,1
community interest message,0,1,0,0,0,1
comparative observational cohort study,0,0,0,1,0,1
compare the difference in respiratory rate between h0,0,0,0,1,0,1
compass,0,0,0,1,0,1
compassion exercises,0,0,0,1,0,1
compassion focused intervention,0,1,0,0,0,1
complement dosage,0,0,0,1,0,1
complete thrombophilic profile testing by multiplex pcr,0,0,0,1,0,1
completion of post telemedicine encounter survey,0,1,0,0,0,1
completion of pre-pandemic survey,0,1,0,0,0,1
completion of survey after peak of pandemic,0,1,0,0,0,1
complex diagnostic panel,0,0,1,0,0,1
comprehensive treatment,0,0,0,1,0,1
conestat alfa,0,0,0,1,0,1
conjunctival swab/nasopharyngeal swab,0,0,0,1,0,1
connected devices measurements,0,0,0,1,0,1
connor-davidson resilience scale 10 items (cd-risc 10),0,0,0,1,0,1
contain covid anxiety ssi,0,1,0,0,0,1
continuation of acei,0,0,0,1,0,1
continuation of acei/arb,0,0,0,1,0,1
continuation of arb,0,0,1,0,0,1
continuation of ras blocker,0,0,0,1,0,1
continued self-enhancement (enhance) for covid-19,0,0,1,0,0,1
continuous blind glucose measurement device (free style pro),0,0,0,1,0,1
continuous positive airway pressure,0,0,0,1,0,1
continuous positive airway pressure (cpap) treatment,0,0,0,1,0,1
continuous renal replacement therapy,0,0,0,1,0,1
continuous vital sign monitoring - isansys patient status engine,0,0,0,1,0,1
contrast-enhanced cmr,0,0,0,1,0,1
contrast-enhanced mri,0,0,0,1,0,1
control blend,0,0,0,1,0,1
control group quality of life assessment,0,1,0,0,0,1
control message,0,1,0,0,0,1
control patients,0,0,0,1,0,1
control swab,0,0,0,1,0,1
control test,0,0,0,1,0,1
controls,0,0,0,1,0,1
convalescent plasma infusion,0,0,0,1,0,1
convalescent plasma/standard care,0,0,0,1,0,1
convalscent plasma,0,0,0,1,0,1
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,",0,0,0,1,0,1
"conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)",0,0,0,1,0,1
conventional oxygen therapy,0,1,0,0,0,1
conventional therapy first,1,0,0,0,0,1
convp,0,0,0,1,0,1
copan swabbing,0,0,0,1,0,1
copan swabbing/blood sample collection,0,0,0,1,0,1
core warming,0,0,0,1,0,1
corn oil (placebo),0,0,0,1,0,1
coromec registry with ecl-19,0,0,1,0,0,1
coronacheck device,0,0,0,1,0,1
coronavac,0,0,0,1,0,1
"coronavirus anxiety scale , covid-19 phobia scale",0,1,0,0,0,1
coronavirus disease 2019,0,0,0,1,0,1
corticosteroid with,0,1,0,0,0,1
corticosteroid with/without colchicine,0,1,0,0,0,1
corticosteroids/derivatives,1,0,0,0,0,1
corvax,0,0,0,1,0,1
cosh self-help smoking cessation booklet,0,0,0,1,0,1
cospherunate,0,0,1,0,0,1
cospherunate/azythromycine,0,0,1,0,0,1
cospherunate/phytomedicine/azythromycien,0,0,1,0,0,1
cost-benefit frame,1,0,0,0,0,1
counselling,1,0,0,0,0,1
couples' group education,0,0,1,0,0,1
covi-vac,0,0,0,1,0,1
covicu,0,0,0,1,0,1
covid-19 / patients,1,0,0,0,0,1
covid-19 androgen sensitivity test (covast),0,0,1,0,0,1
covid-19 antibody testing,0,0,0,1,0,1
"covid-19 antigen/antibody rapid testing, mobile device image capture/telemedicine support",0,0,0,1,0,1
"covid-19 antigen/antibody tests,/influenza rapid test",1,0,0,0,0,1
covid-19 barrier box,0,0,0,1,0,1
covid-19 convalescent plasma (cp),0,0,0,1,0,1
covid-19 diagnostic,0,0,0,1,0,1
covid-19 diagnostic test,0,1,0,0,0,1
covid-19 diagnostic/assessment tests,0,0,0,1,0,1
covid-19 experience surveys,0,0,0,1,0,1
covid-19 facility,0,1,0,0,0,1
covid-19 group,0,0,0,1,0,1
covid-19 group (group i),0,0,0,1,0,1
covid-19 group (group ii),0,0,0,1,0,1
covid-19 infection,0,0,0,1,0,1
covid-19 infection status,0,0,0,1,0,1
covid-19 infection will be conducted.,0,0,0,1,0,1
covid-19 monitoring using wearable sensors,1,0,0,0,0,1
covid-19 monitoring using wearable sensors/smartphone technology,1,0,0,0,0,1
covid-19 nasal,1,0,0,0,0,1
covid-19 nasal/pharyngeal swab,1,0,0,0,0,1
"covid-19 pcr , igm",1,0,0,0,0,1
covid-19 positive,0,0,0,1,0,1
covid-19 positive pregnant women,0,1,0,0,0,1
covid-19 positive via testing,0,0,0,1,0,1
covid-19 presto test,0,0,0,1,0,1
covid-19 related health warning leaflet,0,0,0,1,0,1
covid-19 survey,0,0,0,1,0,1
covid-19 swab,0,0,0,1,0,1
covid-19 test,0,0,0,1,0,1
covid-19 testing,0,0,0,1,0,1
covid-19 treatment,0,0,0,1,0,1
covid-19 treatments,0,1,0,0,0,1
covid-19/ observational,0,0,0,0,1,1
covid-19/intensive care,0,1,0,0,0,1
covid-antibody test,0,0,0,1,0,1
covid-higiv,0,0,0,1,0,1
covid-specific advice,0,0,0,1,0,1
covid-surgres questionaire,0,1,0,0,0,1
covid-viroâ® test,0,1,0,0,0,1
covid 19 diagnostic test,1,0,0,0,0,1
covid 19 impact,0,1,0,0,0,1
covid 19 self-questionnaire,0,0,0,1,0,1
covid 19 serology,0,0,0,1,0,1
covid icu containment measures,0,0,0,1,0,1
covid vaccines,0,0,1,0,0,1
covid watch,1,0,0,0,0,1
covid19 rt-pcr,0,0,0,1,0,1
covid19 treatments,0,1,0,0,0,1
covid19 vaccine,0,0,0,1,0,1
covidseq test,0,0,1,0,0,1
covishield 0.25ml,0,0,0,1,0,1
covishield 0.5ml,0,0,0,1,0,1
covsurf drug delivery system,0,0,0,1,0,1
covx,0,1,0,0,0,1
cpc0.05 oral rinse (perioaidactive control),0,1,0,0,0,1
cpi-006,0,0,0,1,0,1
cpi-006 1 mg,0,0,0,1,0,1
cpi-006 1 mg/kg / soc,0,0,0,1,0,1
cpi-006 2 mg,0,0,0,1,0,1
cpi-006 2 mg/kg / soc,0,0,0,1,0,1
cretan iama,0,1,0,0,0,1
cri management,0,0,1,0,0,1
cries 13 questionnaire,0,0,0,1,0,1
crisis intervention therapy,0,0,1,0,0,1
critical dialogue,0,0,0,1,0,1
crizanlizumab,0,1,0,0,0,1
cross-sectional observational study,0,1,0,0,0,1
cross-sectional study investigating the association of npis with mental health,0,1,0,0,0,1
cross-sectional survey,0,0,0,1,0,1
cross sectional e-survey on surgeons exposed to any educational intervention,1,0,0,0,0,1
cross sectional study using scientifically validated psychometric scales,0,1,0,0,0,1
csl760,0,0,0,1,0,1
cst-2: eidd-2801,0,0,0,1,0,1
cst-2: placebo,0,0,0,1,0,1
csvf,0,0,0,1,0,1
ct-p59/placebo,0,0,0,1,0,1
ctus examination,0,0,0,1,0,1
cube rapid test,1,0,0,0,0,1
cuff application with inflation,0,0,0,1,0,1
cumin,0,1,0,0,0,1
cupping,0,0,0,1,0,1
curosurfâ® (poractant alfa),0,0,0,1,0,1
current care per ucla treating physicians,0,0,0,1,0,1
current clinical practices of participating physicians,0,1,0,0,0,1
current health,0,0,0,1,0,1
current ipac-uhn ppe,0,0,0,1,0,1
cvncov,0,0,0,1,0,1
cvncov 12 î¼g,1,0,0,0,0,1
cvncov 12î¼g,1,0,0,0,0,1
cvncov 6 î¼g,1,0,0,0,0,1
cyp-001,0,0,0,1,0,1
cystatin c,0,0,0,1,0,1
cytokines,0,0,0,1,0,1
cytokines measurement,0,1,0,0,0,1
d,0,0,0,1,0,1
d followed by enoxaparin,0,0,0,1,0,1
daclatasvir 200mg,0,0,0,1,0,1
daily coping toolkit,0,0,0,1,0,1
daily monitoring,0,0,0,1,0,1
daily room disinfection,0,1,0,0,0,1
daily syndromic surveillance,0,0,1,0,0,1
dalcetrapib,0,0,0,1,0,1
danoprevir,0,1,0,0,0,1
danoprevir/ritonavir,0,1,0,0,0,1
dapansutrile capsules,0,0,0,1,0,1
das181,0,1,0,0,0,1
dass-21 instrument (depression,0,0,0,1,0,1
dass-21 instrument (depression/anxiety),0,0,0,1,0,1
dass questionnaire,0,1,0,0,0,1
data,0,0,0,1,0,1
data collecting,0,0,0,1,0,1
data collection from blood draw,0,0,0,1,0,1
data collection from lumbar puncture,0,0,0,1,0,1
data collection from medical files,0,0,0,1,0,1
data collection up to 1 year,0,0,0,1,0,1
data collection/clinical testing of subjects,1,0,0,0,0,1
data collection/rhinopharyngeal swab,0,1,0,0,0,1
data collection: clinical care assessments,0,0,1,0,0,1
data extraction from medical files,0,0,0,1,0,1
data monitoring for 48h within the first 24 hours of admission for covid-19,0,0,0,1,0,1
data registry,0,0,0,1,0,1
"data research, database analysis",0,1,0,0,0,1
day,0,1,0,0,0,1
ddpcr,0,0,0,1,0,1
death with routine,1,0,0,0,0,1
decision tool for clinicians,0,0,0,1,0,1
decisions of limitations,0,0,0,1,0,1
decisions of limitations/stop processing,0,0,0,1,0,1
decitabine,0,0,0,1,0,1
dect,0,0,1,0,0,1
deep breathing training,0,1,0,0,0,1
deferoxamine,0,0,0,1,0,1
defibrotide 25 mg/kg 24 hours continuous infusion for 15 days,0,0,0,1,0,1
degarelix,0,0,0,1,0,1
deglycyrrhizinated licorice,0,0,0,1,0,1
demographic characteristics,0,1,0,0,0,1
depression scale,0,0,0,1,0,1
"depression,",0,0,0,1,0,1
"depression, anxiety",0,0,0,1,0,1
"depression, anxiety/stress scale",0,0,0,1,0,1
derivatives,1,0,0,0,0,1
derivatives.,0,0,0,1,0,1
description of groups caracteristics,0,1,0,0,0,1
desidustat,1,0,0,0,0,1
device used to record voice for screening,0,0,0,1,0,1
device),0,0,0,1,0,1
dexamethasone 2 mg,0,1,0,0,0,1
dexamethasone 2 mg/ml,0,1,0,0,0,1
dexamethasone high dose,0,0,0,1,0,1
dexamethasone low dose,0,0,0,1,0,1
dexamethasone/hydroxychloroquine,0,0,0,1,0,1
dexcom,0,0,0,1,0,1
dfv890,0,1,0,0,0,1
diabetes type 2,1,0,0,0,0,1
diagnosed with covid-19,0,0,1,0,0,1
"diagnosis of sars-cov2 by rt-pcr/: igg, ig m serologies in the amniotoc fluid, the blood cord/the placenta",0,0,0,1,0,1
diagnostic,0,0,0,1,0,1
diagnostic examination for venous thromboembolism,0,1,0,0,0,1
diagnostic test covid-19,1,0,0,0,0,1
diagnostic test for detection of sars-cov-2,0,0,1,0,0,1
diagnostic test for sars-cov2 for patients,0,0,0,1,0,1
diagnostic test for sars-cov2 for patients/health staff,0,0,0,1,0,1
diagnostic tests for covid-19 infection,0,0,0,1,0,1
dialectical behavioral therapy (dbt) skills,0,0,0,1,0,1
diet tracking,0,0,0,1,0,1
"dietary counselling on food groups according to iyc feeding practices, who",0,0,0,1,0,1
dietary supplement,0,0,0,1,0,1
dietary supplement containing resistant starch,0,0,0,1,0,1
dietary supplementation in patients with covid disease admitted to hospital,0,0,0,1,0,1
differences in triage,0,1,0,0,0,1
difficulties lived by disabled children's parents in the period of covid-19 pandemic,0,1,0,0,0,1
diffusing capacity of carbon monoxide,0,0,1,0,0,1
dig axial,1,0,0,0,0,1
dig tilted,1,0,0,0,0,1
digital brochure,0,0,0,1,0,1
digital cardiac counseling,0,0,0,1,0,1
digital health online platform,0,0,0,1,0,1
digital oximeter monitoring,0,0,0,1,0,1
digital problem solving tool,0,1,0,0,0,1
digital social activity video intervention,0,1,0,0,0,1
digital storytelling intervention,0,1,0,0,0,1
digivis visual acuity app,0,0,0,1,0,1
diovan,0,0,0,1,0,1
dipyridamole er 200mg,0,0,0,1,0,1
dipyridamole er 200mg/ aspirin 25mg orally/enterally/standard of care,0,0,0,1,0,1
direct antigen tests for covid-19,0,1,0,0,0,1
discontinuation of acei,0,0,0,1,0,1
discontinuation of acei/arb,0,0,0,1,0,1
discontinuation of arb,0,0,1,0,0,1
discontinuation of ras blocker,0,0,0,1,0,1
discussion board for social support,1,0,0,0,0,1
discussion board for social support /basic feedback,1,0,0,0,0,1
discussion board for social support/personalized feedback,1,0,0,0,0,1
distance learning,0,0,1,0,0,1
distilled water with the same colorant as the experimental product,0,0,0,1,0,1
disulfiram,0,0,0,1,0,1
dlco,0,0,0,1,0,1
dociparstat sodium,0,0,0,1,0,1
doctor spot,0,1,0,0,0,1
doppler echo,0,0,0,1,0,1
dose finding phase (mtd),0,0,0,1,0,1
dose),1,0,0,0,0,1
double-blind nt-i7,0,0,0,1,0,1
doxycyclin,0,0,0,1,0,1
doxycycline hcl,0,0,0,1,0,1
doxycyline,0,1,0,0,0,1
drugs,0,1,0,0,0,1
drugs/supportive care,0,1,0,0,0,1
dry blood spot collection (euroimmun),0,0,0,1,0,1
duact,0,0,0,1,0,1
duplex sonography,0,0,0,1,0,1
duplex ultrasound/computed tomography angiography,0,1,0,0,0,1
dur-928,0,0,0,1,0,1
during covid-19 pandemic,0,0,0,1,0,1
during hospitalization blood samples,0,0,0,1,0,1
"during the pandemic, the patient's job status, physical activity conditions, pain status",0,0,0,1,0,1
dutasteride 0.5 mg,0,1,0,0,0,1
duty frame,1,0,0,0,0,1
dwrx2003,0,0,0,1,0,1
dysautonomia,0,0,0,1,0,1
dysphagia handicap index (dhi),0,0,0,1,0,1
ðžxygen therapy,0,0,0,1,0,1
early-dexamethasone,0,0,0,1,0,1
early rehabilitation,0,0,0,1,0,1
earsats pulse oximeter probe,0,0,0,1,0,1
easycov poc,0,0,0,1,0,1
eat-26 questionnaire,0,1,0,0,0,1
eating habits,0,0,0,1,0,1
ec-18,0,0,0,1,0,1
ecco2r,0,0,0,1,0,1
ecg-holter,0,1,0,0,0,1
echo-doppler,0,0,0,1,0,1
echocardiogram,0,0,0,1,0,1
economic benefit message,0,1,0,0,0,1
economic freedom message,0,1,0,0,0,1
eculizumab,0,0,0,1,0,1
edinburgh postnatal depression scale (edps),0,0,0,1,0,1
education sessions,0,0,0,1,0,1
educational meetings/visual prompts,0,1,0,0,0,1
educational program (cartoon),0,0,0,1,0,1
educational video,1,0,0,0,0,1
eeg,0,1,0,0,0,1
ei open ended pre-survey,0,0,1,0,0,1
ei open ended pre-survey/semi structured interview,0,0,1,0,0,1
eit-group,0,0,0,1,0,1
ejaculated semen sample,0,0,0,1,0,1
elective cancer surgery,0,0,0,1,0,1
electric pad for human external pain therapy,0,0,0,1,0,1
electrical impedance tomography,0,0,0,1,0,1
electrical stimulation,0,0,0,1,0,1
electrical stimulation - sham,0,0,0,1,0,1
electro impedance tomography,0,0,0,1,0,1
electrocardiogram (ecg),0,0,0,1,0,1
"electrocardiogram, telemetry, echocardiogram, laboratory values",0,0,0,1,0,1
"electrocardiogram, transthoracic echocardiography",0,0,0,1,0,1
"electrocardiogram, transthoracic echocardiography/clinico-biological parameters in routine care",0,0,0,1,0,1
"electrocardiography ,tomographic imaging",0,1,0,0,0,1
electrolytes,1,0,0,0,0,1
elisa/rapid test to detect antibodies against covid-19,1,0,0,0,0,1
elispot,0,0,0,1,0,1
elmo project at covid-19: proof of concept,0,0,0,1,0,1
elmo project at covid-19: proof of concept/usability,0,0,0,1,0,1
elmo project at covid-19: study in humans,0,0,0,1,0,1
eltrombopag,0,0,0,1,0,1
emapalumab,0,0,0,0,1,1
embarrassment message,0,1,0,0,0,1
emdr,0,0,0,1,0,1
emergency general surgical admissions,0,1,0,0,0,1
emergency laparotomy,0,1,0,0,0,1
emergency surgery,0,1,0,0,0,1
emergency surgical procedures,0,1,0,0,0,1
emotion regulation training via telehealth,0,0,0,1,0,1
emotional freedom technique,0,1,0,0,0,1
emotional support plan,0,0,0,1,0,1
emphasis of academic researchers involvement,1,0,0,0,0,1
emphasis of government involvement,1,0,0,0,0,1
emtricitabine 200 mg oral tablet,0,0,0,1,0,1
emtricitabine/tenofovir,0,0,0,1,0,1
emtricitabine/tenofovir disoproxil,0,0,0,1,0,1
endoscopic intervention,0,1,0,0,0,1
endoscopic management according to standard of care,0,1,0,0,0,1
endoscopic procedure,0,1,0,0,0,1
endoscopy,0,1,0,0,0,1
endothelial damage,0,0,0,1,0,1
endothelial damage/angiogenic biomarkers,0,0,0,1,0,1
enduring happiness,0,0,1,0,0,1
enduring happiness/continued self-enhancement (enhance) for covid-19,0,0,1,0,0,1
enhanced hygiene measures,1,0,0,0,0,1
enisamium iodide,0,0,0,1,0,1
enoxaparin/lovenox,0,0,0,1,0,1
enriched survey feedback,1,0,0,0,0,1
ensifentrine,1,0,0,0,0,1
ent exam,0,0,0,1,0,1
enterally,0,0,0,1,0,1
entrã©e: behavioral skills,0,0,0,1,0,1
entrã©e: cognitive skills,0,0,0,1,0,1
entrã©e: interpersonal skills,0,0,0,1,0,1
environmental exposure,0,0,0,1,0,1
environmental exposure/clinical features,0,0,0,1,0,1
enzalutamide,0,0,0,1,0,1
ep,0,1,0,0,0,1
epds (edinburgh postnatal depression scale),0,1,0,0,0,1
epic risk score display,0,0,0,1,0,1
epidemiological,0,1,0,0,0,1
epidemiological/demographic characteristics,0,1,0,0,0,1
epidemiology of admissions,0,0,0,1,0,1
epivaccorona (epivaccorona vaccine based on peptide antigens for the prevention of covid-19),1,0,0,0,0,1
equipment with smartwatch throughout hospital stay on the general ward,0,0,0,1,0,1
erucov-vac,0,0,0,1,0,1
escin,0,0,0,1,0,1
essential oil blend,0,0,0,1,0,1
estradiol,0,0,0,1,0,1
ethnic frame,1,0,0,0,0,1
etoposide,0,0,0,1,0,1
euroimmun assay,0,0,0,1,0,1
evaluate hacor score effectivity in this patients,0,0,0,1,0,1
evaluation,0,0,0,1,0,1
evaluation of changes in the diagnostic-therapeutic pathway,0,1,0,0,0,1
"evaluation of clinical, instrumental",0,0,0,1,0,1
"evaluation of clinical, instrumental/laboratory diagnostics tests",0,0,0,1,0,1
evaluation of skin microvascular flow,0,0,0,1,0,1
evaluation of skin microvascular flow/reactivity,0,0,0,1,0,1
evaluation of the epidemiological characteristics of coronavirus infection (sars-cov-2),0,0,0,1,0,1
evaluation of the ferritin,0,0,0,1,0,1
even birth year intervention groups,0,0,0,1,0,1
examinations for the research:,0,0,0,1,0,1
examine the impact of covid-19 during pregnancy,0,0,0,1,0,1
exercise booklet,0,0,0,1,0,1
exercise program,0,0,0,1,0,1
exercise test ecg,0,0,0,1,0,1
exercise/nutrition,0,0,0,1,0,1
exhaled breath sampling,0,1,0,0,0,1
exo-cd24,0,0,0,1,0,1
expanded hemodialysis for covid19 maintenance hemodialysis patients,0,0,0,1,0,1
experiences of health care professionals working in intensive care units during the covid-19 pandemic,0,0,0,1,0,1
experimental group,0,0,0,1,0,1
experimental: questionnaire without precaution information,0,1,0,0,0,1
experts consensus,0,1,0,0,0,1
exposure surveys,0,1,0,0,0,1
exposure to covid-19,0,0,0,1,0,1
exposure to disinfectants during the coronavirus pandemic,0,1,0,0,0,1
exposure to the dutch measures due to the covid-19 pandemic.,0,0,0,1,0,1
extended recovery,0,0,0,1,0,1
extracorporeal blood purification using the oxirisâ® (an69st) hemofilter,0,0,0,1,0,1
extracorporeal left hemicolectomy anastomosis,0,0,0,1,0,1
extracorporeal membrane oxygenation,0,0,0,1,0,1
eye movement desensitisation,0,0,0,1,0,1
eye movement desensitisation/reprocessing recent traumatic event protocol,0,0,0,1,0,1
f-652,0,0,0,1,0,1
face-mask niv,0,0,0,1,0,1
face mask,0,0,0,1,0,1
face mask awareness,0,0,0,1,0,1
face mask sampling,0,0,0,1,0,1
facial fractures reduction,0,1,0,0,0,1
facial fractures reduction/osteosynthesis,0,1,0,0,0,1
facial mask,0,0,0,1,0,1
factors promoting resilience,0,1,0,0,0,1
family nurture intervention (fni),0,0,0,1,0,1
familychildcare (provisional name of app),0,0,1,0,0,1
farmalarm,0,1,0,0,0,1
fast dissolving film,1,0,0,0,0,1
favipiravir / standard care,1,0,0,0,0,1
favipiravir/azithromycin,1,0,0,0,0,1
favipiravir/chloroquine,0,0,0,1,0,1
favipiravir/nitazoxanide,0,0,0,1,0,1
favipiravir/tocilizumab,0,0,0,1,0,1
favorable outcome,0,1,0,0,0,1
fecal,0,0,0,1,0,1
fecal sample,0,0,0,1,0,1
fenofibrate,0,0,1,0,0,1
fenofibrate/fenofibric acid,0,0,1,0,0,1
fenofibric acid,0,0,1,0,0,1
ffp,0,0,0,1,0,1
ffp2,0,0,0,1,0,1
fibreoptic endoscopic evaluation of swallowing (fees),0,0,0,1,0,1
fibrin generation markers assays,1,0,0,0,0,1
fibromyalgia impact questionnaire,0,0,0,1,0,1
file inquiry,0,1,0,0,0,1
filmarray pneumonia,0,1,0,0,0,1
filtration test,0,1,0,0,0,1
fingerstick,0,0,0,1,0,1
fingertip tests for poc assays,0,0,0,1,0,1
fisetin,0,0,1,0,0,1
fitted pva strip,0,0,0,1,0,1
fixed site standard of care testing,0,0,1,0,0,1
flow controlled ventilation (evone-ventilator),0,0,0,1,0,1
flu shot,0,0,1,0,0,1
fluorescein,0,1,0,0,0,1
fluoxetine,0,0,0,1,0,1
fluvoxamine maleate 100 mg [luvox],0,0,0,1,0,1
fmd,0,0,0,1,0,1
fmf.,0,0,1,0,0,1
focused,0,0,0,1,0,1
focused/targeted message,0,0,0,1,0,1
folic acid,1,0,0,0,0,1
follow-up of patients with covid-19,0,0,0,1,0,1
follow-up phone call,0,1,0,0,0,1
follow-up visit,0,0,0,1,0,1
follow up,1,0,0,0,0,1
follow up calls,0,0,0,1,0,1
fondapariniux,0,0,0,1,0,1
formoterol,0,0,0,1,0,1
fotv,0,0,0,1,0,1
foy-305,0,0,0,1,0,1
freestyle libre 14 day cgm system,0,0,0,1,0,1
fsd201,0,0,0,1,0,1
fsfi survey,0,1,0,0,0,1
full spectrum cbd oil,0,0,0,1,0,1
functional mri,0,0,0,1,0,1
further processing of health data,0,0,0,1,0,1
fx06,0,0,0,1,0,1
gad-7 (7-item generalized anxiety disorder),0,1,0,0,0,1
gad-7 (general anxiety disorder) scale,0,1,0,0,0,1
gad-7 (generalized anxiety disorder) scale (during containment),0,0,0,1,0,1
gad-7 (generalized anxiety disorder) scale (post containment),0,0,0,1,0,1
gad-7 general anxiety disorder scale,0,0,0,1,0,1
gam-covid-vac lyo,0,1,0,0,0,1
gamification,0,0,0,0,1,1
gammacoreâ® (vagus nerve stimulation),1,0,0,0,0,1
gammacoreâ® sapphire (non-invasive vagus nerve stimulator),0,0,0,1,0,1
gamunex-c,0,0,0,1,0,1
ganovo,0,1,0,0,0,1
ganovo/ritonavir//-interferon nebulization,0,1,0,0,0,1
"garadacimab, factor xiia antagonist monoclonal antibody",0,1,0,0,0,1
gargle,0,0,0,1,0,1
gas exchange measurement,0,1,0,0,0,1
gas exchanges at different peep,0,1,0,0,0,1
gastrointestinal endoscopy,0,1,0,0,0,1
gastroscopy in transnasal techique,0,0,0,1,0,1
gbp510 (rbd 10î¼g,0,0,0,1,0,1
gbp510 (rbd 10î¼g/dose) - stage 1,0,0,0,1,0,1
gbp510 (rbd 25î¼g,0,0,0,1,0,1
gbp510 (rbd 25î¼g/dose)- stage 2,0,0,0,1,0,1
gbp510 (rbd 25î¼g/dose) - stage 1,0,0,0,1,0,1
gbp510 adjuvanted with alum (rbd 10î¼g,0,0,0,1,0,1
gbp510 adjuvanted with alum (rbd 10î¼g/dose) - stage 1,0,0,0,1,0,1
gbp510 adjuvanted with alum (rbd 10î¼g/dose) - stage 2,0,0,0,1,0,1
gbp510 adjuvanted with alum (rbd 25î¼g,0,0,0,1,0,1
gbp510 adjuvanted with alum (rbd 25î¼g/dose)- stage 2,0,0,0,1,0,1
gbp510 adjuvanted with alum (rbd 25î¼g/dose) - stage 1,0,0,0,1,0,1
gbp510 adjuvanted with as03 (rbd 10î¼g,0,0,0,1,0,1
gbp510 adjuvanted with as03 (rbd 10î¼g/dose) - stage 1,0,0,0,1,0,1
gbp510 adjuvanted with as03 (rbd 10î¼g/dose) - stage 2,0,0,0,1,0,1
gbp510 adjuvanted with as03 (rbd 25î¼g,0,0,0,1,0,1
gbp510 adjuvanted with as03 (rbd 25î¼g/dose)- stage 2,0,0,0,1,0,1
gbp510 adjuvanted with as03 (rbd 25î¼g/dose) - stage 1,0,0,0,1,0,1
gc4419,0,0,0,1,0,1
gc5131,0,0,0,1,0,1
general anesthesia,0,0,0,1,0,1
general communication message,0,0,0,1,0,1
general health education,0,0,0,1,0,1
general public cohort,0,1,0,0,0,1
general recommendation,0,0,0,1,0,1
generalized anxiety disorder-7 (gad-7),0,1,0,0,0,1
generic best practices,0,0,0,1,0,1
genetic,0,0,0,1,0,1
geneva emotional competence test (geco),0,0,1,0,0,1
gimsilumab,1,0,0,0,0,1
global longitudinal strain,0,0,0,1,0,1
global survey,0,1,0,0,0,1
gloves,0,1,0,0,0,1
gls-1200,0,0,0,1,0,1
gls-5310,0,0,0,1,0,1
glucose control,0,1,0,0,0,1
glucose control/sensor usage,0,1,0,0,0,1
glycaemic levels,0,0,0,1,0,1
glycosylated ferritin by standard approved serological tests,0,0,0,1,0,1
gm-csf,1,0,0,0,0,1
gns561,0,0,0,1,0,1
go2 peep mouthpiece,0,1,0,0,0,1
"gps reports of potential patient safety incidents, non-covid-19 related",0,1,0,0,0,1
grad-cov2,0,0,0,1,0,1
grandiosity subscales,0,1,0,0,0,1
grocery store gift cards,0,0,1,0,0,1
group 1,1,0,0,0,0,1
group 1: rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed,0,0,0,1,0,1
group a (ag0302-covid19),1,0,0,0,0,1
group a (placebo),1,0,0,0,0,1
group b (ag0302-covid19),1,0,0,0,0,1
group b (placebo),1,0,0,0,0,1
group1,0,0,0,1,0,1
growth mindset ssi,1,0,0,0,0,1
guided online support program,0,0,0,1,0,1
guilt message,0,1,0,0,0,1
gustatory tests,0,0,0,1,0,1
gx-19,0,0,0,1,0,1
gx-19n,0,0,0,1,0,1
gx-i7,0,0,0,1,0,1
gx-i7 vehicle,0,0,0,1,0,1
h12 of the initiation of morphine between the control,0,0,0,1,0,1
had5-s-fusion,0,0,0,1,0,1
had5-s-fusion/n-etsd vaccine,0,0,0,1,0,1
hads,0,0,0,1,0,1
handwashing stations at the public places,1,0,0,0,0,1
hcfwo,0,0,0,1,0,1
health-related quality of life,0,0,0,1,0,1
health care worker survey,0,0,0,1,0,1
health enhancement program,0,0,0,1,0,1
health literacy,0,0,0,1,0,1
health questionnaire,1,0,0,0,0,1
health staff,0,0,0,1,0,1
health warning leaflet,0,0,0,1,0,1
healthy lifestyle advise,0,0,0,1,0,1
healthy minds program foundations training,0,1,0,0,0,1
helmet niv,0,0,0,1,0,1
helmet non-invasive ventilation,0,0,0,1,0,1
hemodialysis by protein-leaking dialyzer for covid19 maintenance hemodialysis patients,0,0,0,1,0,1
hemodynamics changes at different peep,0,1,0,0,0,1
hemodynamics monitoring,0,1,0,0,0,1
hepatitis a vaccine,1,0,0,0,0,1
herbal phenolic monoterpene,0,0,0,1,0,1
hfb30132a,1,0,0,0,0,1
high-dose placebo (18-59 years),0,0,0,1,0,1
high-dose placebo (18-59 years)/three dose regimen,0,0,0,1,0,1
high-dose placebo (18-59 years)/two dose regimen,0,0,0,1,0,1
high-dose placebo (60-85 years),0,0,0,1,0,1
high-dose placebo (60-85 years)/three dose regimen,0,0,0,1,0,1
high-dose placebo (60-85 years)/two dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years),0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/three dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/two dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years),0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/three dose regimen,0,0,0,1,0,1
high-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/two dose regimen,0,0,0,1,0,1
high-dose vitamin c treatment,1,0,0,0,0,1
high-flow nasal cannula treatment,0,0,0,1,0,1
high dose of kbp-covid-19,0,0,0,1,0,1
high dose radiation 100 cgy,0,0,0,1,0,1
high intensity interval training,0,1,0,0,0,1
high peep with end inspiratory pause,0,0,0,1,0,1
high peep without end inspiratory pause,0,0,0,1,0,1
high touch multi-pronged behavioral intervention,0,0,0,1,0,1
hip arthropalsty,0,1,0,0,0,1
hiv,0,0,0,1,0,1
holter monitor,0,1,0,0,0,1
home-based exercise training,0,0,1,0,0,1
home-cov rule implementation,0,1,0,0,0,1
home-use test,0,0,0,1,0,1
home care monitoring,0,0,0,0,1,1
home exercise,0,0,0,1,0,1
home pulse oximetry monitoring,0,1,0,0,0,1
home sample collection of concerning mole with physician supervision,1,0,0,0,0,1
home sleep apnea testing,1,0,0,0,0,1
home sleep apnea testing/in-hospital polysomnography,1,0,0,0,0,1
home spirometry,0,0,0,1,0,1
hope intervention,1,0,0,0,0,1
"hormone levels (testosterone, fsh, lh, prolactin)",0,0,0,1,0,1
hospital acquired infection,0,0,0,1,0,1
hospital admission,0,0,0,1,0,1
hospital anxiety,0,0,0,1,0,1
hospital anxiety depression measure,0,0,0,1,0,1
hospital anxiety depression scale,0,1,0,0,0,1
hospital anxiety/depression scale,0,0,0,1,0,1
hospital telemedicine management system,0,0,0,1,0,1
hospital: dd-ca,0,0,0,1,0,1
hospital: usual care (uc),0,0,0,1,0,1
"hospitalisation, necessity of icu, mortality rate, lung involvement",0,0,0,1,0,1
hospitalization for premature birth,0,0,1,0,0,1
hospitalized children with covid19,0,0,0,1,0,1
hospitalized patients for covid-19 infection,0,0,0,1,0,1
host genotype,0,0,0,1,0,1
host immune factors,0,0,0,1,0,1
"human coach first, then virtual assistant",0,0,0,1,0,1
human milk donors,0,0,0,1,0,1
human recombinant interleukin 2,0,0,0,1,0,1
humoral,0,0,1,0,0,1
humoral/cellular immunity,0,0,1,0,0,1
hydrocortisone,1,0,0,0,0,1
hydrogen oxygen generator with nebulizer,0,1,0,0,0,1
hydrogen peroxide (b) mouth rinse with the solution provided,0,0,0,1,0,1
hydroxychloroquine / metabolic cofactor supplementation,0,0,0,1,0,1
hydroxychloroquine / oxygen,0,1,0,0,0,1
hydroxychloroquine / sorbitol,0,0,0,1,0,1
hydroxychloroquine sulfate placebo,0,0,1,0,0,1
"hydroxychloroquine, lopinavir",0,0,0,1,0,1
"hydroxychloroquine, lopinavir/ritonavir/azithromycin/placebo (standard therapy)",0,0,0,1,0,1
hydroxychloroquine/azithromycin/ tocilizumab,0,1,0,0,0,1
hydroxychloroquine/clindamycin,0,1,0,0,0,1
hydroxychloroquine/clindamycin/primaquine,0,1,0,0,0,1
hydroxychloroquine/doxycycline,0,1,0,0,0,1
hydroxychloroquine/lopinavir/ritonavir,0,0,0,1,0,1
hydroxychloroquine/placebo,0,0,0,0,1,1
hydroxyvitamin,0,0,0,1,0,1
hyperimmune immunoglobulin to sars-cov-2 (hivig),1,0,0,0,0,1
hypertension,1,0,0,0,0,1
hypothermia via cooling machine- arctic sun 5000,0,0,0,1,0,1
ibudilast,0,0,0,1,0,1
icatibant,0,0,0,1,0,1
icosapent ethyl,0,0,0,1,0,1
icosapent ethyl (ipe),0,0,0,1,0,1
icu recovery,0,0,0,1,0,1
icu recovery / physical therapy,0,0,0,1,0,1
id now vs. accula,0,0,0,1,0,1
identification of genetic variants,0,0,0,1,0,1
idoine complex,0,0,0,1,0,1
ier-r (posttraumatic stress),0,0,0,1,0,1
ifx-1,0,0,0,1,0,1
igg antibodies assay,0,0,0,1,0,1
igg neutralising antibody titers to s1,0,0,0,1,0,1
igg neutralising antibody titers to s1/s2 proteins of sars-cov-2 virus,0,0,0,1,0,1
igg sars cov 2 antibodies,0,1,0,0,0,1
igg sars cov2,1,0,0,0,0,1
"igg, aaz, boulogne-billancourt, france)",1,0,0,0,0,1
igiv,0,0,0,1,0,1
igm test,0,0,1,0,0,1
igm/igg antibodies assay,0,0,0,1,0,1
iibr-100 high-dose (prime),0,0,0,1,0,1
iibr-100 low-dose (prime-boost),0,0,0,1,0,1
iibr-100 medium dose (prime),0,0,0,1,0,1
"iibr-100, low dose (prime)",0,0,0,1,0,1
il-12 plasmid,0,0,0,1,0,1
imaging,0,0,0,1,0,1
imaging by thoracic scanner,1,0,0,0,0,1
imaging characteristics of pneumonia,0,0,0,1,0,1
"imaging, blood tests",0,1,0,0,0,1
imm-101,0,0,0,1,0,1
immediate vs. delayed provision of antibody test results,1,0,0,0,0,1
immune globulin,1,0,0,0,0,1
immune plasma,0,0,0,1,0,1
immune response study,0,0,0,1,0,1
immunfluorescence,0,0,0,1,0,1
immunoformulation,0,1,0,0,0,1
immunofree tablets,0,1,0,0,0,1
immunofree tablets/reginmune capsule,0,1,0,0,0,1
immunoglubulins,0,0,0,1,0,1
immunological,0,0,0,1,0,1
immunosuppressive,0,0,0,1,0,1
immunosuppressive agents,0,0,0,1,0,1
impact event score,0,0,0,1,0,1
impact of event scale-revised,0,0,0,1,0,1
implementation strategy,0,0,0,1,0,1
impulseâ„¢ una e-stethoscope,0,1,0,0,0,1
in-hospital mortality rate,0,1,0,0,0,1
in-person postoperative visit,0,0,0,1,0,1
inactivated sars cov 2 vaccine (vero cell). wuhan,0,0,0,1,0,1
inactivated vaccine,0,0,0,1,0,1
inb03,0,0,0,1,0,1
indian costus,0,0,0,1,0,1
indirect calorimetry,0,0,0,1,0,1
individualized-chinese herbal medicine,0,0,0,1,0,1
indomethacin,0,0,0,1,0,1
infectious disease,0,0,0,1,0,1
infectious disease/cardiology clinical consultations,0,0,0,1,0,1
inflammatory cytokines,0,0,0,1,0,1
inflammatory cytokines/chemokines profiles of patients with dexmedetomidine administration,0,0,0,1,0,1
influenza rapid test,1,0,0,0,0,1
informational sheet,0,1,0,0,0,1
informational videos,0,0,0,1,0,1
informational videos/social media campaigns encouraging cancer screening.,0,0,0,1,0,1
informed consent,0,0,0,1,0,1
inhalation of 5% sodium chloride,0,0,0,1,0,1
"inhalation of 8,4% sodium bicarbonate",0,0,0,1,0,1
inhalation of n-acetylcysteine,0,0,0,1,0,1
inhalation of vitamin c,1,0,0,0,0,1
injectable placebo,0,0,0,1,0,1
injection,0,0,0,1,0,1
injection of secretome-mscs,0,0,0,1,0,1
inm005,0,1,0,0,0,1
innova lateral flow device,0,0,0,1,0,1
inopulse,1,0,0,0,0,1
instrumental activities of daily living shaping,0,0,0,1,0,1
insulin,0,0,0,1,0,1
insulin film,1,0,0,0,0,1
insurance navigation,0,0,0,1,0,1
integrated clinical evaluation,0,0,0,1,0,1
intensive care,0,1,0,0,0,1
intensive care unit admission ratio,0,0,0,1,0,1
interferon-ãÿ-1a,0,0,0,1,0,1
interferon-î² 1a,0,0,1,0,0,1
interferon alfa,0,0,0,1,0,1
interferon î²-1b,0,0,0,1,0,1
interleuken 6,0,0,0,1,0,1
intermediate dose enoxaparin/ unfractionated heparin,0,0,0,1,0,1
intermittent,0,0,0,0,1,1
internet-based cognitive behavioral therapy,1,0,0,0,0,1
internet-based guided self-help based on cbt principles,0,0,0,1,0,1
internet-based self-help,0,0,0,1,0,1
internet-based self-help after 3 weeks,0,0,0,1,0,1
internet-delivered cognitive behavior therapy (icbt) for dysfunctional worry related to the covid-19 pandemic,1,0,0,0,0,1
intervention app,0,1,0,0,0,1
intervention group coronacope,0,0,0,1,0,1
intervention group_rehabilitation program,0,0,0,1,0,1
intervention program,0,0,0,1,0,1
interventional groups,0,0,0,1,0,1
interview by psychologists,0,0,0,1,0,1
intestinal microbiota,0,0,0,1,0,1
intracorporeal left hemicolectomy anastomosis,0,0,0,1,0,1
intramuscular injection,0,0,0,1,0,1
intranasal ivermectin spray,0,0,0,1,0,1
intraosseous,0,1,0,0,0,1
intravenous,0,1,0,0,0,1
intravenous drug,0,0,0,1,0,1
introductory phone call (cc,0,0,1,0,0,1
invasive mechanical ventilation,0,1,0,0,0,1
invasive mechanical ventilation using the unisabana-herons ventilator during 24 hours,0,1,0,0,0,1
investigation of smell,0,1,0,0,0,1
investigation of smell/taste disorders,0,1,0,0,0,1
investigation of the prevalence of test positivity,0,0,0,1,0,1
investigational product - viracide,0,0,0,1,0,1
iota carrageenan nasal spray,0,1,0,0,0,1
iota carrageenan nasal spray/ivermectin oral drops (used as buccal drops),0,1,0,0,0,1
ip-10,0,1,0,0,0,1
irl201104,0,0,0,1,0,1
isis 721744,1,0,0,0,0,1
isoflurane inhalant product,0,0,0,1,0,1
isoquercetin,0,0,0,1,0,1
itolizumab,0,1,0,0,0,1
its,0,0,0,1,0,1
iv tocillizumab (tcz),0,0,0,1,0,1
ivermectin (iver pâ®) arm will receive ivm 600 âµg,0,1,0,0,0,1
ivermectin (iver pâ®) arm will receive ivm 600 âµg / kg once daily/standard care. control arm will receive standard care.,0,1,0,0,0,1
ivermectin / doxycycline,0,1,0,0,0,1
ivermectin / doxycycline / placebo,0,1,0,0,0,1
ivermectin / iota-carrageenan,0,1,0,0,0,1
ivermectin / placebo,0,1,0,0,0,1
ivermectin 3 mg,0,0,0,1,0,1
"ivermectin 5 mg/ml oral solution, aspirin 250 mg tablets",0,1,0,0,0,1
ivermectin impregnated mask,0,0,0,1,0,1
ivermectin pill,0,0,0,1,0,1
ivermectin/deamethisone/aspirin,0,1,0,0,0,1
ivermectin/deamethisone/exoparin,0,1,0,0,0,1
ivermectin/doxycycline,0,1,0,0,0,1
ivermectin/doxycyline,0,1,0,0,0,1
ivig,0,1,0,0,0,1
ixekizumab,0,0,0,1,0,1
"jinhua qinggan (jhqg) granules, traditional chinese medicine",0,0,0,1,0,1
kaletra,0,0,0,1,0,1
kaletra/beta interferon,0,0,0,1,0,1
kamada anti-sars-cov-2,0,1,0,0,0,1
kelea water,0,0,0,1,0,1
ketamine,0,0,0,1,0,1
ketogenic diet,0,0,0,1,0,1
ketogenic diet with phytoextracts,0,0,0,1,0,1
ketotifen,0,1,0,0,0,1
kg 24 hours continuous infusion for 15 days,0,0,0,1,0,1
kg eb05 iv,0,0,0,1,0,1
kg once daily,0,1,0,0,0,1
kidney biopsy,1,0,0,0,0,1
kir phenotype evaluation,0,1,0,0,0,1
"knowledge, attitude, practice, awareness, preference",0,1,0,0,0,1
kundalini yoga,0,0,0,1,0,1
kundalini yoga/anxiety reduction training,0,0,0,1,0,1
l. reuteri dsm 17938,0,0,0,1,0,1
l. reuteri dsm 17938 / vitamin d,0,0,0,1,0,1
lab workup (on admission,0,0,0,1,0,1
lab workup (on admission/regularly during follow up).,0,0,0,1,0,1
laboratory,0,0,0,1,0,1
laboratory analyses,0,0,0,1,0,1
laboratory diagnostics tests,0,0,0,1,0,1
laboratory test positive for sars-cov-2 virus,0,0,1,0,0,1
laboratory values,0,1,0,0,0,1
labs,0,0,0,1,0,1
lactobacillus,0,0,0,1,0,1
lactobaciltus rhamnosus gg,0,0,0,1,0,1
"lactoferrin, green tea extract",0,0,0,1,0,1
lambda 180 mcg s.c,0,0,0,1,0,1
lamp,0,1,0,0,0,1
lanadelumab placebo,0,0,0,1,0,1
laparoscopic,0,1,0,0,0,1
laparoscopic/open appendicectomy,0,1,0,0,0,1
laryngoscope,1,0,0,0,0,1
laryngoscopy,0,1,0,0,0,1
lateral position (left,0,0,0,1,0,1
lateral position (left/right lateral decubitus),0,0,0,1,0,1
lau-7b,0,0,0,1,0,1
lay telephone coaching,0,0,1,0,0,1
leaf-4l6715,0,0,0,1,0,1
let it out (lio)-c,0,0,0,0,1,1
leukapheresis,0,0,0,1,0,1
levamisole,0,0,0,1,0,1
levamisole / budesonide/formoterol,0,0,0,1,0,1
levilimab,0,1,0,0,0,1
liberase enzyme,0,0,0,1,0,1
licensed seasonal influenza vaccine,0,0,0,1,0,1
licorice extract,0,0,0,1,0,1
lidocaine 2%,0,0,0,1,0,1
life2000â® ventilator,0,0,0,1,0,1
lifesignals biosensor 1ax*,0,0,0,1,0,1
lifestyle (exercise),0,1,0,0,0,1
lifestyle (meditation),0,1,0,0,0,1
lifestyle change promotion program,0,0,0,1,0,1
lifestyle habits,0,1,0,0,0,1
lift,0,0,0,1,0,1
limbix spark,0,0,0,1,0,1
linagliptin,0,0,0,1,0,1
linagliptin 5 mg,0,0,0,1,0,1
liposomal,0,1,0,0,0,1
liquid alpha1-proteinase inhibitor (human),0,0,0,1,0,1
liver,0,0,1,0,0,1
liver function tests,0,1,0,0,0,1
"liver, lung, heart",1,0,0,0,0,1
"liver, lung, heart/kidney biopsy",1,0,0,0,0,1
lmwh,0,1,0,0,0,1
lock-down,0,1,0,0,0,1
lock-down/social distancing,0,1,0,0,0,1
longeveron mesenchymal stem cells (lmscs),0,0,0,1,0,1
lopinavir 200 mg,1,0,0,0,0,1
lopinavir 200 mg / ritonavir 50 mg [kaletra],1,0,0,0,0,1
lopinavir/ ritonavir,0,0,0,1,0,1
lopinavir/ ritonavir/remdesivir combination,1,0,0,0,0,1
lopinavir/ritonavir / hydoxychloroquine,0,0,0,1,0,1
lopinavir/ritonavir 200 mg-50 mg oral tablet,0,0,0,1,0,1
losartan 50 mg,0,0,0,1,0,1
losartan 50 mg/spironolactone 25 mg pillules oral use,0,0,0,1,0,1
losmapimod,0,0,0,1,0,1
lovenox,0,0,0,1,0,1
low-dose placebo (18-59 years),0,0,0,1,0,1
low-dose placebo (18-59 years)/three dose regimen,0,0,0,1,0,1
low-dose placebo (18-59 years)/two dose regimen,0,0,0,1,0,1
low-dose placebo (60-85 years),0,0,0,1,0,1
low-dose placebo (60-85 years)/three dose regimen,0,0,0,1,0,1
low-dose placebo (60-85 years)/two dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years),0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/three dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (18-59 years)/two dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years),0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/three dose regimen,0,0,0,1,0,1
low-dose recombinant covid-19 vaccine (sf9 cells) (60-85 years)/two dose regimen,0,0,0,1,0,1
low-molecular-weight heparin,0,0,0,1,0,1
low dose low molecular weight heparin,0,0,0,1,0,1
low dose low molecular weight heparin/placebo,0,0,0,1,0,1
low dose of kbp-covid-19,0,0,0,1,0,1
low dose prednisolone,0,0,0,1,0,1
low peep - fio2 high,0,0,0,1,0,1
low peep - fio2 low,0,0,0,1,0,1
low/upper respiratory tract sample,0,0,0,1,0,1
lsalt peptide,0,0,0,1,0,1
lung ct scan analysis in covid-19 patients,0,0,0,1,0,1
lung function test,0,0,1,0,0,1
lung function tests,0,0,0,1,0,1
lung impedance,0,0,0,1,0,1
lung low dose radiation,0,0,0,1,0,1
lung mechanics at different peep,0,1,0,0,0,1
lung ultrasonography,0,1,0,0,0,1
lung ultrasound use in patients hospitalized with covid,0,0,0,1,0,1
lv-smenp-dc vaccine,0,0,0,1,0,1
lv-smenp-dc vaccine/antigen-specific ctls,0,0,0,1,0,1
ly3127804,0,0,0,0,1,1
lyt-100,0,0,0,1,0,1
m-m-r ii â® vaccine,0,0,0,1,0,1
m5049,0,0,0,1,0,1
machine learning,0,0,0,1,0,1
machine learning classification of parenchymal lung change cause,0,0,0,1,0,1
machine learning classification of recurrence,0,0,0,1,0,1
machine learning classification of recurrence/non-recurrence,0,0,0,1,0,1
machine learning model,0,1,0,0,0,1
machine learning/ai algorithm,0,0,0,1,0,1
magec spine rod,0,0,0,1,0,1
magnesium stearate),0,0,0,1,0,1
magnetic resonance imaging,0,0,0,1,0,1
magnetic resonance spectroscopy (mrs).,0,0,0,1,0,1
maintenance,0,0,0,1,0,1
makair,0,0,0,1,0,1
management of covid-19,0,0,0,1,0,1
management strategy of outpatient with mild to moderate sars-cov-2 pneumonia,0,1,0,0,0,1
manremyc,0,0,0,1,0,1
marker therapeutics d2000 cartridge (d2000) for use with the spectra optiaâ® apheresis system (optia spd protocol),0,0,0,1,0,1
mas825,1,0,0,0,0,1
"masimo, lidco",0,0,0,1,0,1
masitinib,0,0,0,1,0,1
masked saline placebo,0,0,0,1,0,1
maslach burnout inventory (mbi),0,1,0,0,0,1
masseter inhibitory reflex,0,0,0,1,0,1
massive parallel sequencing of host genome,0,0,0,1,0,1
"maternal attachment, edinburgh depression scoring",0,1,0,0,0,1
"maternal attachment, edinburgh depression scoring/postpartum anxiety scale scores",0,1,0,0,0,1
maternal stress,0,0,0,1,0,1
matrix m1-adjuvant,0,0,0,1,0,1
maximal effort test,0,0,0,1,0,1
mcc ims,0,1,0,0,0,1
mcgrath videolaryngoscope,1,0,0,0,0,1
measurement of circulating sflt1 concentration,0,0,0,1,0,1
measurement of respiratory muscle force,0,0,0,1,0,1
mechanical trombectomy,0,1,0,0,0,1
media intervention,0,0,0,1,0,1
medical follow-up,0,0,0,1,0,1
medical mask,0,0,0,1,0,1
medical record review - inpatient treatment,0,0,0,1,0,1
medication review,0,0,0,1,0,1
meditation app usage,0,0,0,1,0,1
meditation therapy,0,0,0,1,0,1
meditation/anxiety reduction training,0,0,0,1,0,1
medium dosage inactivated sars-cov-2 vaccine on a 0-/14-day schedule,0,0,0,1,0,1
medium dose prednisolone,0,0,0,1,0,1
mefloquine/azithromycin/ tocilizumab,0,1,0,0,0,1
mejoracare,0,0,0,1,0,1
melatonin intravenous,0,0,0,1,0,1
melphalan,0,0,0,1,0,1
memory b-cell function,1,0,0,0,0,1
menacwy prime,0,0,0,1,0,1
menacwy prime/saline placebo boost / paracetamol,0,0,0,1,0,1
menacwy single dose,0,0,0,1,0,1
menacwy single dose / paracetamol,0,0,0,1,0,1
menacwy vaccine,0,0,0,1,0,1
mencare,0,0,1,0,0,1
mencare//bandebereho fathers'/couples' group education,0,0,1,0,0,1
mental imagery,0,0,0,1,0,1
mental well-being,0,1,0,0,0,1
meplazumab,0,0,0,1,0,1
merimepodib,0,0,0,0,1,1
mesenchymal stromal cell-based therapy,0,0,0,1,0,1
mesenchymalÂ stem cells/heparin,0,1,0,0,0,1
mesencure,0,0,0,1,0,1
messaging,0,1,0,0,0,1
metabolic cofactor supplementation,0,0,0,1,0,1
metabolomic,0,0,0,1,0,1
metanebâ® system,0,0,0,1,0,1
metenkefalin,0,1,0,0,0,1
metenkefalin / tridecactide,0,1,0,0,0,1
metformin,0,0,0,1,0,1
metformin extended release oral tablet,0,0,0,1,0,1
metformin glycinate,0,0,0,1,0,1
methotrexate-lde phase 1,0,0,0,1,0,1
methotrexate-lde phase 2,0,0,0,1,0,1
methylene-blue photodisinfection,0,0,0,1,0,1
methylene blue/ vitamin c/n-acetyl cysteine,0,0,0,1,0,1
methylprednisolone injectable product,0,0,0,1,0,1
methylprednisolone injection,0,1,0,0,0,1
mf59 adjuvanted sars-cov-2 sclamp vaccine,0,0,0,1,0,1
mfs,0,0,0,1,0,1
mhealth assessments,0,0,0,1,0,1
mhealth platform,0,0,0,1,0,1
microcirculation recording,0,0,0,1,0,1
micronized,0,0,0,1,0,1
"micronized/ultra-micronized palmitoylethanolamide (mpea/umpea, 300mg / 600mg) oral suspension",0,0,0,1,0,1
microscopy of defined brain regions on autopsy specimens,0,0,0,1,0,1
mindfullness training,0,1,0,0,0,1
mindfulness-based cognitive therapy,0,0,0,1,0,1
mindfulness-based stress reduction,0,0,0,1,0,1
mindfulness session(s),1,0,0,0,0,1
mindfulness training,0,0,0,1,0,1
minimal attention control intervention,0,0,0,0,1,1
miniprobe alveoflex,0,0,0,1,0,1
"minus formula, huhuang detoxicity paste, baimu qingre jiedu paste",1,0,0,0,0,1
"minus formula, huhuang detoxicity paste, baimu qingre jiedu paste, fumigation",1,0,0,0,0,1
ml intravenous solution [actemra]_#1,0,0,0,1,0,1
ml intravenous solution [actemra]_#1 (2 doses),0,0,0,1,0,1
"ml oral solution, aspirin 250 mg tablets",0,1,0,0,0,1
"ml oral solution, dexamethasone 4-mg injection, aspirin 250 mg tablets",0,1,0,0,0,1
"ml oral solution, dexamethasone 4-mg injection, enoxaparin injection. inpatient treatment with mechanical ventilation in icu.",0,1,0,0,0,1
ml prefilled syringe [kineret],0,0,0,1,0,1
mls laser,0,1,0,0,0,1
mmrc (modified medical research council) dyspnea scale,0,0,0,1,0,1
mobile internet survey on self-test,0,1,0,0,0,1
mobile mental health app - 1,0,0,1,0,0,1
mobile mental health app - 2,0,0,1,0,0,1
mobile mental health app - 3,0,0,1,0,0,1
mobile mental health app - 4,0,0,1,0,0,1
modafinil,0,1,0,0,0,1
model building,0,1,0,0,0,1
model validation,0,1,0,0,0,1
moderate intensity aerobic exercises,0,1,0,0,0,1
modification,0,1,0,0,0,1
modified ipac-uhn ppe,0,0,0,1,0,1
modified rankin score,0,1,0,0,0,1
molecular hydrogen,0,0,0,1,0,1
molgramostim nebuliser solution,0,0,0,1,0,1
mometasone furoate nasal spray,0,1,0,0,0,1
monalizumab,0,0,0,1,0,1
monitoring,0,0,0,1,0,1
monitoring for aggravation,0,0,0,1,0,1
monitoring visit,0,0,0,0,1,1
monoclonal antibody,0,0,0,1,0,1
montelukast,0,1,0,0,0,1
month 12 after first symptoms from sars-cov-2 infection,0,0,0,1,0,1
montmorrillonite,0,1,0,0,0,1
mortality,0,0,0,1,0,1
motivational messages,1,0,0,0,0,1
mouthrinse with bãªta-cyclodextrin,0,1,0,0,0,1
mouthrinse with bãªta-cyclodextrin/citrox,0,1,0,0,0,1
mouthrinse without bãªta-cyclodextrin,0,1,0,0,0,1
mouthrinse without bãªta-cyclodextrin/citrox,0,1,0,0,0,1
moxibustion,0,0,0,1,0,1
moxibustion/cupping,0,0,0,1,0,1
mr,0,0,0,1,0,1
mr-pro-adm,0,0,0,1,0,1
mr/m-m-r ii â® vaccine,0,0,0,1,0,1
mrg-001,0,0,0,1,0,1
"mri (heart, brain, lungs, liver)",0,0,0,1,0,1
mri scans,0,0,0,1,0,1
mrna in urine test,0,1,0,0,0,1
mrx-4dp0004,0,0,0,1,0,1
msc,0,0,0,1,0,1
mstt1041a,0,1,0,0,0,1
mucodentol,0,0,0,1,0,1
multicapillary column coupled ion mobility spectrometry,0,0,0,1,0,1
multifrequency bioimpedance spectroscopy,0,0,0,1,0,1
multipeptide cocktail,0,0,0,1,0,1
multistem,0,0,0,1,0,1
multitest 6 color tbnk,0,0,0,1,0,1
multitest 6 color tbnk/bd lyotubes,0,0,0,1,0,1
multivitamin with 11mg of zinc,0,0,1,0,0,1
muscle biopsy,0,0,0,1,0,1
muscle relaxation therapy,0,0,0,1,0,1
musclesound ultrasound,0,0,0,1,0,1
mva-sars-2-s vaccinations (days 0,0,0,0,1,0,1
mva-sars-2-s vaccinations (days 0/28),0,0,0,1,0,1
mvc-cov1901,1,0,0,0,0,1
mvc-cov1901(s protein with adjuvant),0,0,0,1,0,1
mvc-cov1901(saline),0,0,0,1,0,1
n-acetyl cysteine,1,0,0,0,0,1
n-acetyl glucosamine (nag),1,0,0,0,0,1
n-etsd vaccine,0,0,0,1,0,1
n95 respirator,0,0,0,1,0,1
na-831/atazanavir,0,0,0,1,0,1
na-831/dexamethasone,0,0,0,1,0,1
na (no intervention),0,0,0,1,0,1
nä°cas,0,0,0,1,0,1
nad,0,0,0,1,0,1
nad/,0,0,0,1,0,1
nanomix elabâ® covid-19 rapid antigen panel (non-interventional),0,0,0,1,0,1
nasal high flow,0,1,0,0,0,1
nasal lavage,0,0,1,0,0,1
naser al-husban,0,1,0,0,0,1
nasopharyngeal (np) swab,1,0,0,0,0,1
nasopharyngeal samples.,0,0,0,1,0,1
nasopharyngeal/throat swab,0,1,0,0,0,1
nasopharyngeal/throat/oropharyngeal swabs analyses by rt-pcr/ddpcr,0,0,0,1,0,1
nasopharynx,0,0,0,0,1,1
nasovax,0,0,0,1,0,1
navigation services,0,0,0,1,0,1
nbp2001 adjuvanted with alum (rbd 30î¼g,1,0,0,0,0,1
nbp2001 adjuvanted with alum (rbd 30î¼g/dose),1,0,0,0,0,1
nbp2001 adjuvanted with alum (rbd 50î¼g,1,0,0,0,0,1
nbp2001 adjuvanted with alum (rbd 50î¼g/dose),1,0,0,0,0,1
nbt-nm108,0,0,0,1,0,1
ncapp,0,0,0,1,0,1
nebulised heparin,0,0,0,1,0,1
nebulised recombinant tissue-plasminogen activator (rt-pa),0,0,0,1,0,1
nebulised unfractionated heparin (ufh),0,0,0,1,0,1
nebulized furosemide,0,0,0,1,0,1
nebulized platelet lysate,0,0,0,1,0,1
nebulized saline,0,0,0,1,0,1
nebulized sterile saline,0,0,0,1,0,1
netosis markers,0,0,0,1,0,1
neural network diagnosis algorithm,0,0,0,1,0,1
neurocognitive assessment,0,0,0,1,0,1
neuroimaging findings in patients with covid-19,0,1,0,0,0,1
neurology test,0,0,1,0,0,1
neuromuscular,0,0,0,1,0,1
neuromuscular electrical stimulation,0,0,0,1,0,1
neuropsychological assessment,0,0,0,1,0,1
neutral writing control,0,0,0,0,1,1
new ppe,0,1,0,0,0,1
newborns,0,1,0,0,0,1
next generation sequencing (ngs) analysis,0,0,0,1,0,1
ng test,0,0,0,1,0,1
ngm621,0,0,0,1,0,1
nhanes smell,0,0,0,1,0,1
nhanes smell/taste tests,0,0,0,1,0,1
niclosamide / camostat,0,0,0,1,0,1
niclosamide oral tablet,0,0,0,1,0,1
niclosamide suspension,0,0,0,1,0,1
nicotinamide,0,0,0,1,0,1
nicotinamide riboside,0,0,0,1,0,1
nicotine 7 mg,0,0,0,1,0,1
nicotine 7 mg/ 24h transdermal patch - 24 hour,0,0,0,1,0,1
nicotine patch,0,0,0,1,0,1
nigella sativa / black cumin,0,1,0,0,0,1
nigella sativa oil,0,0,0,1,0,1
nintedanib,0,0,0,1,0,1
nintedanib 150 mg [ofev],0,0,0,1,0,1
nioâ® (intraosseous access),0,1,0,0,0,1
nitazoxanide / ivermectin,0,0,0,1,0,1
nitazoxanide/atazanavir/ritonavir,0,0,0,1,0,1
nitric oxide delivered via lungfitâ„¢ system,0,0,0,1,0,1
"nitric oxide lozenges, 30 mg",0,0,0,1,0,1
nitroglycerin,0,0,0,1,0,1
nk-1r antagonist,0,0,0,1,0,1
no-immunosuppressive,0,0,0,1,0,1
no activities of the hbcc project,1,0,0,0,0,1
no instruction regarding positioning,0,0,0,1,0,1
no intervention (survey study for medical doctors).,0,1,0,0,0,1
no intervention planned due to the observational study design only a diagnostic testing,0,0,1,0,0,1
no intervention. method study. psychometric testing,0,0,0,1,0,1
no intervention; observational study,0,0,0,1,0,1
no interventional study,1,0,0,0,0,1
"no interventions performed. just collecting data, blood samples",0,0,0,1,0,1
"no interventions performed. just collecting data, blood samples/post-mortem biopsies.",0,0,0,1,0,1
no messaging,1,0,0,0,0,1
no personal protective equipment (ppe),0,1,0,0,0,1
no racial inequality highlighting,1,0,0,0,0,1
no research related technology based social interactions,0,0,1,0,0,1
no special intervention,0,1,0,0,0,1
non,0,0,1,0,0,1
non-acei,1,0,0,0,0,1
non-acei/arb,1,0,0,0,0,1
non-contact mce system,0,1,0,0,0,1
non-hospitalization procedures,0,0,0,1,0,1
non-interventional study,0,0,0,1,0,1
non-invasive ventilatory support,1,0,0,0,0,1
non-mindfulness intervention,0,0,0,1,0,1
non-operative management,0,0,1,0,0,1
non-recurrence,0,0,0,1,0,1
non intervention,0,0,0,1,0,1
non interventional study,0,0,0,1,0,1
non invasive visual acuity testing,1,0,0,0,0,1
none - na,0,1,0,0,0,1
none - observational,0,0,0,1,0,1
"none, this study is observational",0,1,0,0,0,1
noninvasive ventilation,0,1,0,0,0,1
noninvasive ventilation treatment,0,0,0,1,0,1
normal saline intranasal,0,0,0,1,0,1
"nose swabs, bronchoalveolar lavage ,urine)",0,0,0,1,0,1
nosocomial,0,0,0,1,0,1
not applicable (na),0,0,0,1,0,1
not applicable (observational study),0,0,0,1,0,1
not bravery message,0,1,0,0,0,1
not required,0,1,0,0,0,1
nowdx covid-19 test,0,0,1,0,0,1
nox66,0,0,0,1,0,1
np-120 (ifenprodil),1,0,0,0,0,1
nps test,0,0,0,1,0,1
nricm101,0,0,0,1,0,1
nudge,0,0,0,0,1,1
nusepinâ® 0.1 mg,0,0,0,1,0,1
nusepinâ® 0.2 mg,0,0,0,1,0,1
nutrition consult,0,0,0,1,0,1
nutrition consult/protein supplementation,0,0,0,1,0,1
nutritional assessment,0,0,0,1,0,1
nutritional intervention,0,0,0,1,0,1
nuvastatic,0,0,0,1,0,1
obesity,1,0,0,0,0,1
observation for study group,1,0,0,0,0,1
observation of covid 19 pneumonia,0,0,0,1,0,1
observation of different courses of sars-cov-2 infection in different phases (acute vs. post-acute),0,0,0,1,0,1
observation of different courses of sars-cov-2 infection in different phases (acute vs. post-acute)/settings,0,0,0,1,0,1
observational cohort study on the natural history of hospitalized sars-cov-2 patients.,0,0,0,1,0,1
observational measurement of biometric data. no change to health care provided.,0,0,0,1,0,1
observational study - no intervention,0,0,0,1,0,1
"obtainment of nasopharyngeal, oropharyngeal, buccal, nasal",0,0,0,1,0,1
"obtainment of nasopharyngeal, oropharyngeal, buccal, nasal/saliva samples",0,0,0,1,0,1
obvio-19 app,0,0,0,1,0,1
occupational health workers,0,0,0,1,0,1
octaplas,0,0,0,1,0,1
odd,0,0,0,1,0,1
odd/even birth year intervention groups,0,0,0,1,0,1
old ppe,0,1,0,0,0,1
olfaction testing,0,0,0,1,0,1
olfactometry,0,0,0,1,0,1
olfactory,0,0,0,1,0,1
olfactory device,0,0,0,1,0,1
olfactory function evaluation,0,1,0,0,0,1
olfactory/gustatory tests,0,0,0,1,0,1
olokizumab,0,1,0,0,0,1
omega 3/nigella sativa oil,0,0,0,1,0,1
omega 3/nigella sativa oil/anise seed capsule,0,0,0,1,0,1
omega 3/nigella sativa oil/deglycyrrhizinated licorice,0,0,0,1,0,1
omega 3/nigella sativa oil/indian costus,0,0,0,1,0,1
omega 3/nigella sativa oil/quinine pills,0,0,0,1,0,1
omegavenâ®,0,0,0,1,0,1
omeprazole,0,0,0,1,0,1
omnibiotic aad,0,0,0,1,0,1
one covid-19 vaccine candidate (tmv-083) administration - high dose,0,0,0,1,0,1
online cognitive stimulation therapy,0,0,0,1,0,1
online intervention grief covid-19,0,0,0,1,0,1
online intervention mental health covid-19,0,0,0,1,0,1
op-101,0,0,0,1,0,1
open appendicectomy,0,1,0,0,0,1
operative management,0,0,1,0,0,1
ophtamesone,0,0,0,1,0,1
opt-in recruitment email,1,0,0,0,0,1
opt-out recruitment email,1,0,0,0,0,1
optical coherence tomography (oct),0,0,0,1,0,1
optical coherence tomography angiography,0,1,0,0,0,1
optimized management of covid-19 positive kidney transplant recipients: single center experience from the middle east,0,1,0,0,0,1
optional interview,0,0,0,1,0,1
or antiplatelet) before admission for covid19,0,1,0,0,0,1
or high dose lmwh),0,0,0,1,0,1
or mis-c exposure,0,0,0,1,0,1
"or psychotherapy, n=10)",1,0,0,0,0,1
oral,0,0,0,1,0,1
oral ivermectin,0,0,0,1,0,1
oral polio vaccine / information,0,0,1,0,0,1
oropharyngeal,0,0,0,1,0,1
oropharyngeal swabs analyses by rt-pcr,0,0,0,1,0,1
oropharyngeal/intestinal microbiota,0,0,0,1,0,1
ortd-1 high dose,0,0,0,1,0,1
ortd-1 low dose,0,0,0,1,0,1
ortd-1 mid dose,0,0,0,1,0,1
orthopaedic surgical procedures,0,1,0,0,0,1
oseltamivir 75mg,0,0,0,1,0,1
osoc,0,0,0,0,1,1
osteosynthesis,0,1,0,0,0,1
other clinical symptoms,0,1,0,0,0,1
other vaccine against sars-cov-2,0,0,0,1,0,1
otilimab,1,0,0,0,0,1
overnight intensive recovery,0,0,0,1,0,1
overnight intensive recovery / extended recovery,0,0,0,1,0,1
oxaloacetate medical food,0,0,0,1,0,1
oxaloacetate medical food/dietary supplement,0,0,0,1,0,1
oxidative stress elisa kit,0,0,0,1,0,1
oximenâ® 3%,0,1,0,0,0,1
oxygen-ozone,0,0,0,1,0,1
oxygen hood,0,1,0,0,0,1
oxyhydrogen,0,0,0,1,0,1
ozanimod,0,0,0,1,0,1
ozone,0,0,0,1,0,1
p2et (caesalpinia spinosa extract),0,0,0,1,0,1
pacritinib,0,0,0,1,0,1
pamrevlumab,0,0,0,1,0,1
pandemic control measures,0,0,0,1,0,1
paraclinical examination,0,0,0,1,0,1
paraclinical test,0,0,0,1,0,1
parents during induction,0,0,0,1,0,1
part 1 - tl-895,0,0,0,1,0,1
part 2 - tl-895,0,0,0,1,0,1
part a,0,0,0,1,0,1
part a/b: placebo,0,0,0,1,0,1
part a: upamostat 200 mg,0,0,0,1,0,1
part a: upamostat 400 mg,0,0,0,1,0,1
part b: upamostat 200,0,0,0,1,0,1
part b: upamostat 200/400 mg,0,0,0,1,0,1
partially hla-matched sars-covsts,0,0,0,1,0,1
participate in a massive musical event,0,1,0,0,0,1
particle measurement,0,1,0,0,0,1
passed infection of sars-cov-2,0,1,0,0,0,1
passive microwave radiometry,0,1,0,0,0,1
"patch, nicotine",0,0,0,1,0,1
"patch, placebo",0,0,0,1,0,1
patient-centred advice on telephone consultation in tb patients:,0,0,0,1,0,1
patient characteristics,0,1,0,0,0,1
patient quality of life assessment,0,1,0,0,0,1
patient sampling,0,0,0,1,0,1
patient status engine,0,0,0,1,0,1
patient with sar-cov-2 infection,0,0,0,1,0,1
patients,1,0,0,0,0,1
patients admitted in intensive care units,0,0,0,1,0,1
patients admitted to intensive care unit with sars-cov2,1,0,0,0,0,1
patients covid 19,0,0,0,1,0,1
patients received standard of care treatment during hospitalization,0,0,0,1,0,1
patients with the treatment agains covid19,0,0,0,1,0,1
pbmt,0,1,0,0,0,1
pbmt/smf,0,1,0,0,0,1
pcr test,0,0,0,1,0,1
pcr value,0,0,0,1,0,1
pcr/chest ct,0,1,0,0,0,1
pct,0,0,0,1,0,1
pct/serology,1,0,0,0,0,1
peep,0,0,0,1,0,1
peer resilience champion,1,0,0,0,0,1
peer support,0,0,1,0,0,1
peginterferon beta-1a,0,0,0,1,0,1
pegylated interferon-î±2b,0,0,0,1,0,1
pembrolizumab,0,0,0,1,0,1
pemziviptadil (pb1046),0,0,0,0,1,1
pentaglobin,0,0,0,1,0,1
pentoxifylline,1,0,0,0,0,1
pep flute,0,0,0,1,0,1
perceived stress scale,0,0,0,1,0,1
percutaneous coronary revascularization for stemi,1,0,0,0,0,1
performance evaluation,0,0,0,1,0,1
performance evaluation study of realdetect rt-pcr kit for covid-19 detection,0,0,0,1,0,1
performance of the test antigenic,0,1,0,0,0,1
performance of the test antigenic/test rt-pcr,0,1,0,0,0,1
performing ai algorithms on images,0,0,0,1,0,1
performing of lung ultrasound,0,0,0,1,0,1
peripheral venous ultrasound,0,0,0,1,0,1
personal freedom message,0,1,0,0,0,1
personal protective equipment,0,0,0,1,0,1
personal protective equipment (ppe),0,1,0,0,0,1
personal protective equipment from biological hazard,0,1,0,0,0,1
personal protective measures,0,1,0,0,0,1
personal protective testing booth,1,0,0,0,0,1
personalized ambulatory training,0,0,0,1,0,1
personalized feedback,1,0,0,0,0,1
personalized health education,0,0,0,1,0,1
pet-ct of 18f-fdg,0,1,0,0,0,1
pf-06650833,0,0,0,1,0,1
pf-07304814,0,0,0,1,0,1
pharyngeal swab,1,0,0,0,0,1
phase 1,0,0,0,1,0,1
phase 2,0,0,0,1,0,1
philips lumify ultrasound system,0,1,0,0,0,1
phlebotomy,0,0,0,1,0,1
phobia questionairre,0,0,0,1,0,1
phone call interview,0,0,0,1,0,1
phone interviews,0,0,0,1,0,1
phq,0,1,0,0,0,1
phq-9 depression scale,0,0,0,1,0,1
phr160 spray,0,0,0,1,0,1
phsyiotherapy,1,0,0,0,0,1
physical,0,0,0,1,0,1
physical activity program,0,0,0,1,0,1
physical examination,0,0,0,1,0,1
physical/cognitive activity,0,0,0,1,0,1
physiological effects of awake prone position in covid 19 patients,0,0,0,1,0,1
phytomedicine,0,0,1,0,0,1
piclidenoson,0,0,0,1,0,1
pilot a rapid sars-cov-2 testing strategy,0,0,1,0,0,1
pioglitazone,0,1,0,0,0,1
pioglitazone 30 mg,0,0,0,1,0,1
piperacillin,0,0,0,1,0,1
piperacillin/tazobactam,0,0,0,1,0,1
placebo-lde phase 2,0,0,0,1,0,1
placebo - phase i,1,0,0,0,0,1
placebo (methylcellulose) capsule,0,0,0,1,0,1
placebo (potato starch,0,0,0,1,0,1
placebo (potato starch/magnesium stearate),0,0,0,1,0,1
placebo (saline),0,0,0,1,0,1
placebo (standard therapy),0,0,0,1,0,1
"placebo (two doses), priming",0,0,0,1,0,1
placebo / soc,0,0,0,1,0,1
placebo / vitamin d,0,0,0,1,0,1
placebo booster,0,0,0,1,0,1
placebo control (non-behavioral infographic),0,1,0,0,0,1
placebo empty capsule,0,0,0,1,0,1
placebo for abbv-47d11,0,0,0,1,0,1
placebo for camostat mesilate,0,0,0,1,0,1
placebo hydroxychloroquine,0,0,0,1,0,1
placebo iv,0,0,0,1,0,1
placebo magnesium,0,0,0,1,0,1
placebo nitazoxanide,0,0,0,1,0,1
placebo of fx06,0,0,0,1,0,1
placebo of nicotine transdermal patch,0,0,0,1,0,1
placebo oil,0,0,0,1,0,1
placebo patch,0,0,0,1,0,1
placebo ribavirin,0,0,0,1,0,1
placebo videos,1,0,0,0,0,1
placebo/aluminum adjuvant of inactivated sars-cov-2 vaccine,1,0,0,0,0,1
placebo/control,0,0,0,1,0,1
plant polyphenol,0,0,0,1,0,1
plasma exchange/convalescent plasma,0,0,0,1,0,1
plasma igg levels,0,0,0,1,0,1
"platelet count, platelet, mean platelet volume",0,0,0,1,0,1
"platelet count, platelet, mean platelet volume/platelet distribution width in covid-19",0,0,0,1,0,1
platelet distribution width in covid-19,0,0,0,1,0,1
"platelet function analyzer scp1, sienco, usa",0,1,0,0,0,1
plethysmography,0,0,0,1,0,1
plethysmography/dlco,0,0,0,1,0,1
plitidepsin,0,1,0,0,0,1
pln-74809,0,0,0,1,0,1
pneumococcal vaccine,1,0,0,0,0,1
point-of-care rapid anti-sars-cov-2 antibody test (orient gene biotech),0,0,0,1,0,1
point-of-care rapid anti-sars-cov-2 antibody test (orient gene biotech)/dry blood spot collection (euroimmun),0,0,0,1,0,1
point-of-care test for sars-cov-2,0,0,0,1,0,1
"point of care ultrasound including echocardiography, lung ultrasound, vascular ultrasound",0,0,0,1,0,1
polio vaccine,0,0,1,0,0,1
polio vaccine/na-831,0,0,1,0,0,1
polyoxidonium,0,1,0,0,0,1
polysomnography,1,0,0,0,0,1
pool lamp,0,1,0,0,0,1
pool rt-pcr,0,1,0,0,0,1
poractant alfa,0,0,0,1,0,1
position,0,0,0,1,0,1
positive feedback,0,1,0,0,0,1
positive for sars-cov-2 infection,0,0,0,1,0,1
post-intensive care unit syndrome,0,0,0,1,0,1
post-mortem biopsies.,0,0,0,1,0,1
post-traumatic stress screening,0,0,0,1,0,1
post covid-19 functional satus scale,0,0,0,1,0,1
postpartum,0,0,1,0,0,1
postpartum anxiety scale scores,0,1,0,0,0,1
postpartum women under investigation for coronavirus/diagnosed with covid-19,0,0,1,0,0,1
postural positioning,0,0,0,1,0,1
povidone,0,0,0,1,0,1
power breathe,0,0,0,0,1,1
prazosin,0,0,0,1,0,1
pre-operative screening,0,0,0,1,0,1
predict admission of covid-19 patients to icu,1,0,0,0,0,1
"predict admission of covid-19 patients to icu/death with routine/quickly avalaible clinical, biological/radiological variables?",1,0,0,0,0,1
prediction market,0,1,0,0,0,1
predictive factors for clinical response in patients with covid-19.,0,0,0,1,0,1
predictors adverse evolution,0,0,0,1,0,1
predictors of health care provide,0,0,0,1,0,1
prednisone tablet,0,0,0,1,0,1
pregnant women under investigation for coronavirus,0,0,1,0,0,1
pregnant women under investigation for coronavirus/diagnosed with covid-19,0,0,1,0,0,1
presence of specific anti-sars-cov-2 antibodies,0,1,0,0,0,1
preservative-free saline,0,0,0,1,0,1
preservision areds formulation soft gels,0,0,1,0,0,1
preservision areds formulation soft gels/tablets,0,0,1,0,0,1
prevalence of covid-19,0,1,0,0,0,1
primary care,0,1,0,0,0,1
"primary care professionals reports of potential patient safety incidents, non-covid-19 related",0,0,0,1,0,1
primepro,0,1,0,0,0,1
pro-sero-cov,1,0,0,0,0,1
"pro bnp , vitamin d",0,0,0,1,0,1
probiorinse,0,0,0,1,0,1
probiotics,0,1,0,0,0,1
probiotics (2 strains 10x10^9 ufc),0,0,0,1,0,1
problem-solving,0,0,0,1,0,1
problem-solving/relationship improvement intervention.,0,0,0,1,0,1
procalcitonin,0,0,0,1,0,1
produce prescription program,0,0,1,0,0,1
progesterone,0,1,0,0,0,1
prognostic score,1,0,0,0,0,1
progressive cycling exercise test to exhaustion,0,1,0,0,0,1
progressive muscle relaxation,0,1,0,0,0,1
project echo,0,0,0,1,0,1
prolastin,0,0,0,1,0,1
prolectin-m; a (1-6)-alpha-d-mannopyranose class,0,1,0,0,0,1
prolonged proned positioning,0,0,0,1,0,1
prone lying position,0,1,0,0,0,1
proper diet,0,0,0,1,0,1
prophylactic,0,0,0,1,0,1
prophylaxis,0,1,0,0,0,1
propofol,0,0,0,1,0,1
prospective chart review,0,0,1,0,0,1
prospective oberservational registry,0,0,0,1,0,1
protective ventilation,0,0,0,1,0,1
protein supplementation,0,0,0,1,0,1
prototype,0,0,0,1,0,1
proxalutamide,0,1,0,0,0,1
psc-04,0,0,0,1,0,1
psg,0,0,0,1,0,1
psqi,0,1,0,0,0,1
pss,0,1,0,0,0,1
psychoeducation,0,0,0,1,0,1
psychoeducational intervention,0,0,0,1,0,1
psychological rehabilitation,0,0,0,1,0,1
psychological stress,0,1,0,0,0,1
psychological stress/adaptation at work score (psas),0,1,0,0,0,1
psychological/behaviour change support,0,0,0,1,0,1
psychological/sociological interviews,1,0,0,0,0,1
psychometric scale administration,0,0,0,1,0,1
psychotherapy,0,0,0,1,0,1
ptc299,0,0,0,1,0,1
ptsd,0,0,0,1,0,1
ptsd check list (pcl) scale,0,0,0,1,0,1
public health england gold standard,0,0,0,1,0,1
pulmonary anomalies 4 months after documented covid-19 pneumonia,1,0,0,0,0,1
pulmonary function testing,0,0,0,1,0,1
pulmonary physiotherapy techniques,0,1,0,0,0,1
pulmonary tele-rehabilitation,0,0,0,1,0,1
pulmozyme/ recombinant human deoxyribonuclease (rh-dnase),0,0,0,1,0,1
pulse oximeter,1,0,0,0,0,1
pulse oximetry,0,1,0,0,0,1
pwv,0,0,0,1,0,1
pyridostigmine bromide,0,0,0,1,0,1
q-nrg metobolic cart device,0,0,0,1,0,1
q spect-ct,0,0,0,1,0,1
qazcovid-inâ®-vaccine against covid-19,0,0,1,0,0,1
qazcovid-inâ® - covid-19 inactivated vaccine,0,1,0,0,0,1
qrt-pcr,0,0,1,0,0,1
qrt-pcr/serology,0,0,1,0,0,1
quadramune(tm),0,0,0,1,0,1
qualitative,0,0,0,1,0,1
qualitative assessments of mental health,0,0,0,1,0,1
qualitative interviews..,0,0,0,1,0,1
qualitative/quantitative virus pcr of respiratory secretions in patients with high aerosol concentrations,0,0,0,1,0,1
quality of life promotion,1,0,0,0,0,1
quality of life questionnaires,0,0,0,1,0,1
quality of live assessment,0,1,0,0,0,1
quantitative,0,0,0,1,0,1
quantitative analysis of anti-sars-cov-2-antibodies,0,1,0,0,0,1
quantitative analysis of sars-cov-2 antibodies,0,1,0,0,0,1
quantitative igg test,1,0,0,0,0,1
quantitative virus pcr of respiratory secretions in patients with high aerosol concentrations,0,0,0,1,0,1
quantitative/qualitative assessments of mental health,0,0,0,1,0,1
quantra system,0,0,1,0,0,1
quasistatic pressure-volume curve,0,0,0,1,0,1
quercetin phytosome,0,0,0,1,0,1
querying the insee database,0,0,0,1,0,1
questionaire,0,1,0,0,0,1
questionnaire : preparedness for caregiving scale,0,0,0,1,0,1
"questionnaire, phone call",0,0,0,1,0,1
questionnaire/interview,0,1,0,0,0,1
questionnaire/optional interview,0,0,0,1,0,1
questionnaires family,0,0,0,1,0,1
questionnaires on psychological quality of life,0,1,0,0,0,1
questionnaires patient,0,0,0,1,0,1
"quickly avalaible clinical, biological",1,0,0,0,0,1
quinine,0,0,0,1,0,1
quinquina-stevia,0,0,1,0,0,1
quinquina-stevia/azythromycin,0,0,1,0,0,1
r tablets,1,0,0,0,0,1
racial,1,0,0,0,0,1
racial inequality highlighted,1,0,0,0,0,1
racial/ethnic frame,1,0,0,0,0,1
radiological lung involvement evolution,0,0,0,1,0,1
radiological variables?,1,0,0,0,0,1
"raman analysis of saliva, characterization of the raman database",0,0,0,1,0,1
"raman analysis of saliva, characterization of the raman database/building of the classification model",0,0,0,1,0,1
ramipril,0,0,0,1,0,1
randomized booster,0,0,0,1,0,1
rapa-501-allo off-the-shelf therapy of covid-19,0,0,0,1,0,1
rapid-3,0,0,0,1,0,1
rapid antibody test,0,0,0,1,0,1
rapid antigen test,0,0,0,1,0,1
rapid antigen test for sars cov2,0,1,0,0,0,1
rapid molecular test,0,0,0,1,0,1
rapid salivary test,0,1,0,0,0,1
rarefaction,0,0,0,1,0,1
rayaldee 30mcg extended-release (er) capsule,0,0,0,1,0,1
razuprotafib,0,0,0,1,0,1
razuprotafib subcutaneous solution,0,0,0,1,0,1
rbt-9 (90 mg),0,0,0,1,0,1
rd-x19,0,1,0,0,0,1
rdv,0,0,0,1,0,1
reactivity,0,0,0,1,0,1
reading a book,0,1,0,0,0,1
recharge,0,0,0,1,0,1
recombinant human interferon î±2b spray,1,0,0,0,0,1
recombinant human plasma gelsolin (rhu-pgsn),0,0,0,1,0,1
recombinant new coronavirus vaccine (cho cell) group,0,0,0,1,0,1
recombinant novel coronavirus vaccine (adenovirus type 5 vector) -placebo,0,0,0,1,0,1
recombinase,0,0,0,1,0,1
rectal swab,0,0,0,1,0,1
referral,0,0,0,1,0,1
referral card,0,0,0,1,0,1
referral/digital brochure,0,0,0,1,0,1
reframing,0,1,0,0,0,1
reginmune,0,1,0,0,0,1
registery data collection,0,0,0,1,0,1
regular care,0,0,0,1,0,1
regularly during follow up).,0,0,0,1,0,1
rehabilitation by concentric exercises,0,0,0,1,0,1
rehabilitation by eccentric exercises,0,0,0,1,0,1
rehabilitation of cognitive function after remission of the symptoms of covid-19,0,0,0,1,0,1
rehabilitation protocol through a digital platform,0,0,0,1,0,1
relation between frailty,0,0,0,1,0,1
relation between frailty/clinical outcomes in elderly patients with covid-19.,0,0,0,1,0,1
relationship improvement intervention.,0,0,0,1,0,1
relationship scales questionnaire (rsq),0,0,0,1,0,1
relaxation,0,0,0,1,0,1
remain covid free ssi,0,1,0,0,0,1
remdesivir-hu,1,0,0,0,0,1
remdesivir combination,1,0,0,0,0,1
remestemcel-l,1,0,0,0,0,1
remote cognitive behavioral therapy for insomnia,0,0,0,1,0,1
remote controlled exercise,0,0,0,1,0,1
remote pulmonary rehabilitation,0,0,0,1,0,1
removal of dead space filter,0,0,0,1,0,1
renin-angiotensin system inhibitors,0,0,0,1,0,1
repeat sars-cov-2 igg antibodies at 45-65 days,0,1,0,0,0,1
"reporting of anosmia, ageusia",0,1,0,0,0,1
"reporting of anosmia, ageusia/other clinical symptoms",0,1,0,0,0,1
reprocessing recent traumatic event protocol,0,0,0,1,0,1
research specific blood sample,0,0,0,1,0,1
resilience program,0,0,0,1,0,1
resp-aer-meter,0,0,0,1,0,1
"resp301, a nitric oxide generating solution",0,0,0,1,0,1
respiratory,0,0,0,1,0,1
respiratory function rehabilitation training,0,0,0,1,0,1
respiratory mechanics measurement,0,1,0,0,0,1
respiratory monitor,0,0,0,1,0,1
respiratory monitoring,0,0,0,1,0,1
respiratory muscles ultrasound,0,0,0,1,0,1
respiratory physiotherapy,0,1,0,0,0,1
respiratory rehabilitation,0,0,0,1,0,1
respiratory rehabilitation program (rr).,0,0,0,1,0,1
respiratory swabs,0,0,0,1,0,1
"respiratory symptoms, symptoms of anxiety",0,0,0,1,0,1
"respiratory symptoms, symptoms of anxiety/depression,/post-traumatic stress screening",0,0,0,1,0,1
respiratory tele-rehabilitation program (trr).,0,0,0,1,0,1
respiratory tract sample,0,0,0,1,0,1
respiratory training,0,0,0,1,0,1
respiratory/psychological rehabilitation,0,0,0,1,0,1
resting 12 lead ecg,0,0,0,1,0,1
resveratrol,0,0,0,1,0,1
retrospective,0,0,0,1,0,1
retrospective case-control analysis,0,1,0,0,0,1
retrospective data collection,0,0,0,1,0,1
retrospective metagenomics on clinical samples collected during hospitalization,1,0,0,0,0,1
reverse transcription polymerase chain reaction,0,1,0,0,0,1
review of medical patient file,0,0,0,1,0,1
revised home-cov score,0,0,0,1,0,1
reward re-training,0,0,0,1,0,1
rh-dnase,0,0,0,1,0,1
rhace2,0,1,0,0,0,1
rhdnase i,0,0,0,1,0,1
rhea health toneâ®,0,0,0,1,0,1
rhinopharyngeal,0,1,0,0,0,1
rhtpo,0,0,0,1,0,1
ria-device (remote investigation,0,1,0,0,0,1
ria-device (remote investigation/assessment),0,1,0,0,0,1
ribaroxaban,0,0,0,1,0,1
right lateral decubitus),0,0,0,1,0,1
rintatolimod,0,0,0,1,0,1
risankizumab,0,0,0,1,0,1
risk factors,0,1,0,0,0,1
ritonavir 200 mg-50 mg oral tablet,0,0,0,1,0,1
ritonavir 50 mg [kaletra],1,0,0,0,0,1
ritonavir/oseltamivir,0,0,0,1,0,1
rivaroxaban 15mg tab,0,0,0,1,0,1
rnapc2,0,0,0,1,0,1
roactemra,0,0,0,0,1,1
robot assisted percutaneous cardiovascular intervention,0,0,0,1,0,1
robotic assisted early mobilization,0,0,0,1,0,1
robotic therapy,0,0,0,1,0,1
rosuvastatin,0,0,0,1,0,1
routine care (no sars-covsts),0,0,0,1,0,1
rph-104,0,1,0,0,0,1
rt-qpcr test,0,1,0,0,0,1
s2 proteins of sars-cov-2 virus,0,0,0,1,0,1
sab-185,0,0,0,1,0,1
saint george respiratory questionnaire,0,0,1,0,0,1
saline-sodium citrate (ssc) buffer,0,0,0,1,0,1
saline containing 1% human serum albuminï¼ˆsolution without uc-mscsï¼‰,0,1,0,0,0,1
saline placebo boost,0,0,0,1,0,1
saline with baby shampoo nasal irrigation,1,0,0,0,0,1
saline/standard care,1,0,0,0,0,1
saliva assay,0,0,1,0,0,1
saliva based assay: crude rna extraction,0,0,0,1,0,1
saliva collected via salivette cortisol,0,1,0,0,0,1
saliva test kit,0,0,0,1,0,1
saliva/nps test,0,0,0,1,0,1
salivary,0,1,0,0,0,1
samba ii,0,0,0,1,0,1
sample,0,0,0,1,0,1
sample collection/performance evaluation (a),0,0,0,1,0,1
sample collection/performance evaluation (b),0,0,0,1,0,1
sampler skills,0,0,0,1,0,1
sampling by venipuncture,0,0,0,1,0,1
sampling of oropharynx,0,0,0,0,1,1
sampling of oropharynx/nasopharynx,0,0,0,0,1,1
sampling of sars-cov-2 rna from nasopharyngeal swab specimen,0,1,0,0,0,1
sampling of sars-cov-2 rna from nasopharyngeal swab specimen/saliva collected via salivette cortisol,0,1,0,0,0,1
sar443122,0,1,0,0,0,1
sarilumab prefilled syringe,0,0,0,1,0,1
sars-cov-2-test,0,0,0,1,0,1
sars-cov-2 ab,0,1,0,0,0,1
sars-cov-2 and,0,0,0,1,0,1
sars-cov-2 and/or mis-c exposure,0,0,0,1,0,1
sars-cov-2 antibody analysis,0,0,1,0,0,1
sars-cov-2 antibody based ivig therapy,0,1,0,0,0,1
sars-cov-2 antibody immunoassays,1,0,0,0,0,1
sars-cov-2 antibody test,0,0,0,1,0,1
sars-cov-2 antibody testing,0,0,0,1,0,1
sars-cov-2 antigen-specific cytotoxic t-lymphocytes,0,0,0,1,0,1
sars-cov-2 ig g levels,0,0,0,1,0,1
sars-cov-2 igg,0,0,0,1,0,1
sars-cov-2 inactivated vaccine,0,0,0,1,0,1
sars-cov-2 infection,1,0,0,0,0,1
sars-cov-2 neutralizing antibody titer,0,0,0,1,0,1
sars-cov-2 rapid diagnostic test (covid-prestoâ® igm,1,0,0,0,0,1
"sars-cov-2 rapid diagnostic test (covid-prestoâ® igm/igg, aaz, boulogne-billancourt, france)",1,0,0,0,0,1
"sars-cov-2 research in nasopharyngeal swab, sperm",0,0,0,1,0,1
"sars-cov-2 research in nasopharyngeal swab, sperm/serologics",0,0,0,1,0,1
sars-cov-2 rs/matrix m1-adjuvant,0,0,0,1,0,1
sars-cov-2 s1,0,1,0,0,0,1
sars-cov-2 s1/s2 igg,0,1,0,0,0,1
sars-cov-2 serological assessment (igg),0,0,0,1,0,1
sars-cov-2 serology,0,0,0,1,0,1
sars-cov-2 specific t cells,0,0,0,1,0,1
sars-cov-2 vaccine,0,0,0,1,0,1
sars-cov-2 vaccine formulation 1 with adjuvant 1,1,0,0,0,0,1
sars-cov-2 vaccine formulation 1 with adjuvant 2,1,0,0,0,0,1
sars-cov-2 vaccine formulation 2 with adjuvant 1,1,0,0,0,0,1
sars-cov-2 vaccine formulation 2 with adjuvant 2,1,0,0,0,0,1
sars-cov-2 vaccine formulation 2 without adjuvant,1,0,0,0,0,1
sars-cov-2 viral composition,0,0,0,1,0,1
sars-cov-2 virus vaccines,0,0,0,1,0,1
sars-cov2 testing,0,0,0,1,0,1
satisfaction evaluation,0,0,0,1,0,1
savr,1,0,0,0,0,1
sbi-101,0,0,0,1,0,1
scanning chest x-rays/performing ai algorithms on images,0,0,0,1,0,1
scarcity message,0,1,0,0,0,1
scb-2019,1,0,0,0,0,1
scb-2019 with as03 adjuvant,1,0,0,0,0,1
scb-2019 with cpg 1018 adjuvant,1,0,0,0,0,1
scb-2019 with cpg 1018 adjuvant/alum adjuvant,1,0,0,0,0,1
scd,0,0,0,1,0,1
sch intervention,0,0,1,0,0,1
scta01,0,1,0,0,0,1
sedation,0,0,0,1,0,1
self-administered questionnaire,0,1,0,0,0,1
self-care tools,0,0,1,0,0,1
"self-collected, home-based testing",0,0,1,0,0,1
self-compassion for chronic pain virtual group treatment program,0,0,0,1,0,1
self-help booklet,1,0,0,0,0,1
self-help mindfulness,0,0,0,1,0,1
self-help mindfulness/compassion exercises,0,0,0,1,0,1
self-interest message,0,1,0,0,0,1
self-management booklet (switch: stay well during covid-19),0,0,0,1,0,1
self-questionnary,0,0,0,1,0,1
self-reported symptom collection,0,0,0,1,0,1
self measurement with pulse oximeter,0,0,0,1,0,1
self study,0,0,0,1,0,1
semen analysis,0,1,0,0,0,1
semen qualitative analysis,1,0,0,0,0,1
semi-structured telephone questionnaire,0,0,0,1,0,1
semi structured interview,0,0,1,0,0,1
sending thorax ct video images via smartphone applications,0,1,0,0,0,1
senicapoc,0,0,0,1,0,1
sensor usage,0,1,0,0,0,1
sequence of testing.,0,0,0,1,0,1
sequencing,0,0,0,1,0,1
seraph,0,0,0,1,0,1
seraphâ®-100 microbindâ® affinity blood filter,0,0,0,1,0,1
serial seroconversion measurements in hospital employees during the covid-19 pandemic,0,0,0,1,0,1
serologic assays for antibodies to sars-cov-2,0,0,0,1,0,1
serologic immunoassays to sars-cov-2 antibodies,0,0,0,1,0,1
serologic test,0,0,0,1,0,1
serological covid-19 vaccine immunogenicity,0,0,0,1,0,1
serological surveillance,0,0,0,1,0,1
serological testing for covid-19 infection,0,0,0,1,0,1
serological tests for sars cov-2,0,1,0,0,0,1
serology test follow-up,1,0,0,0,0,1
serology test for covid-19,0,0,0,1,0,1
seroprevalence of sars-cov-2 infection in patients with hiv infection,0,0,0,1,0,1
serum,1,0,0,0,0,1
serum neurofilaments as a marker of neurological damage.,0,0,0,1,0,1
serum neutralization,0,0,0,1,0,1
serum ngal,0,0,0,1,0,1
serum ngal/cystatin c,0,0,0,1,0,1
serum protein level analysis,0,1,0,0,0,1
service of questionnaire,0,1,0,0,0,1
sessions,1,0,0,0,0,1
settings,0,0,0,1,0,1
severe acute respiratory syndrome coronavirus 2 detection,0,1,0,0,0,1
severity of lung involvement with covid-19.,0,1,0,0,0,1
sfc (5-ala,0,0,0,1,0,1
sfc),0,0,0,1,0,1
sham inflation,0,0,0,1,0,1
shanshamani vati plus,0,1,0,0,0,1
shared decision making,0,0,1,0,0,1
shg,0,1,0,0,0,1
"shingrix (zoster vaccine recombinant, adjuvanted)",0,0,0,1,0,1
sildenafil,0,0,0,1,0,1
sildenafil citrate,0,0,0,1,0,1
silymarin,0,0,0,1,0,1
simha kriya,0,1,0,0,0,1
simple chest tomography,0,1,0,0,0,1
simulation of repurposed drugs for covid-19,1,0,0,0,0,1
simvastatin,0,0,0,1,0,1
single high dose vitamin d,0,0,0,1,0,1
single passive leg movement,0,0,0,1,0,1
sirukumab,0,0,0,1,0,1
sit-to-stand test,0,0,0,1,0,1
sit to stand test,0,0,0,1,0,1
six-minute walk test (6mwt),0,0,0,1,0,1
six minutes walk test,0,0,0,1,0,1
sledd with a l-mod,0,0,0,1,0,1
smartphone-based voice,0,0,0,1,0,1
smartphone-based voice/self-reported symptom collection,0,0,0,1,0,1
smartphone technology,1,0,0,0,0,1
smell training,0,0,0,1,0,1
smf,0,1,0,0,0,1
sms-based support,0,0,0,1,0,1
sms message support,1,0,0,0,0,1
soc / ifx-1,0,0,0,1,0,1
soc / intravenous famotidine,0,1,0,0,0,1
soc/15mg/kg eb05 iv,0,0,0,1,0,1
soc/placebo iv,0,0,0,1,0,1
social distancing,0,1,0,0,0,1
social media,0,1,0,0,0,1
social media campaigns encouraging cancer screening.,0,0,0,1,0,1
social media/news consumption,0,1,0,0,0,1
social proof,0,1,0,0,0,1
socialization,0,0,0,1,0,1
sodium chloride,0,0,0,1,0,1
sofosbuvir 400 mg,0,0,0,1,0,1
sofosbuvir 400 mg/daclatasvir 200mg,0,0,0,1,0,1
sofosbuvir ledipsavir,0,0,0,1,0,1
soluble urokinase plasminogen activator receptor,1,0,0,0,0,1
solution-focused support program,0,0,0,1,0,1
sonclot coagulation,0,1,0,0,0,1
"sonclot coagulation/platelet function analyzer scp1, sienco, usa",0,1,0,0,0,1
sonoclot,0,0,0,1,0,1
SOP,0,0,0,1,0,1
sorbitol,0,0,0,1,0,1
soterix tavns model 0125-lte stimulator - active-active group,0,0,0,1,0,1
soterix tavns model 0125-lte stimulator - sham-active group,0,0,0,1,0,1
spartan covid-19 system,0,1,0,0,0,1
spartan covid-19 test,0,0,0,1,0,1
spartan covid-19 v2 system,0,0,0,1,0,1
specific anti-sars-cov-2 antibodies,0,0,0,1,0,1
specific exercise rehabilitation treatment,0,0,0,1,0,1
specimen collection,0,0,0,1,0,1
specimens specific for the study,0,0,0,1,0,1
speed of processing training,0,0,0,1,0,1
speq (specific psychotic experiences questionnaire) - paranoia,0,1,0,0,0,1
speq (specific psychotic experiences questionnaire) - paranoia/grandiosity subscales,0,1,0,0,0,1
sperm test,0,0,0,1,0,1
sphenopalatine ganglion block with local anesthetic,0,0,0,1,0,1
sphenopalatine ganglion block with placebo (isotone nacl),0,0,0,1,0,1
spin-chat program,0,1,0,0,0,1
"spirometry, thoracic ct, cpet, 6 minute walking test, sf-36 questionnaire",0,0,1,0,0,1
spironolactone 25 mg pillules oral use,0,0,0,1,0,1
splenic ultrasound,0,0,1,0,0,1
sputnik light,1,0,0,0,0,1
sse educational intervention,1,0,0,0,0,1
st. george's respiratory questionnaire (sgrq),0,0,0,1,0,1
staff wellbeing centres,0,0,0,1,0,1
standard care/monitoring,0,0,0,1,0,1
standard care/placebo,0,0,0,1,0,1
standard charity resources,0,0,0,1,0,1
standard interface,0,1,0,0,0,1
standard of care thromboprophylaxis,0,0,0,1,0,1
standard oxygen delivery system,0,0,0,1,0,1
standard prophylactic dose enoxaparin,0,0,0,1,0,1
standard prophylactic dose enoxaparin/ unfractionated heparin,0,0,0,1,0,1
"standard q covid-19 ag - test, produced by sd biosensor inc.",0,0,0,1,0,1
standard therapy protocol (stp),0,0,0,1,0,1
standard treatment of covid-19,0,0,0,1,0,1
state-trait anxiety inventory scale,0,0,0,1,0,1
statins,1,0,0,0,0,1
stc-19,0,1,0,0,0,1
steam inhalations,0,0,0,1,0,1
stellate ganglion block,0,0,0,1,0,1
sti-5656,0,0,0,1,0,1
stigma awareness video intervention,0,1,0,0,0,1
stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by covid-19 infection,0,0,0,1,0,1
stools,0,0,0,1,0,1
stop processing,0,0,0,1,0,1
stp,0,0,0,1,0,1
stp / covid-19 convalescent plasma (cp),0,0,0,1,0,1
stp / standard plasma (sp),0,0,0,1,0,1
stress,0,0,0,1,0,1
stress first aid,0,0,0,1,0,1
stress scale,0,0,0,1,0,1
stress/anxiety questionnaire,0,0,0,1,0,1
study a,0,0,0,1,0,1
study arm,0,0,0,1,0,1
study b,0,0,0,1,0,1
study c,0,0,0,1,0,1
study d,0,0,0,1,0,1
study of immune-mediated mechanisms in patients tested positive for sars-cov-2,0,0,0,1,0,1
subacute rehabilitation,0,0,0,1,0,1
sublingual methylene blue,0,0,0,1,0,1
sudarshan kriya yoga (sky),0,0,0,1,0,1
sulfur hexafluoride lipid-type a microspheres,0,0,0,1,0,1
sulodexide,0,1,0,0,0,1
supine position,0,0,0,1,0,1
supine positioning,0,0,0,1,0,1
support as usual,0,0,0,1,0,1
supportive therapy,0,0,0,1,0,1
supportive therapy ssi,1,0,0,0,0,1
supportive tratment,0,0,0,1,0,1
supportive/symptomatic treatment,1,0,0,0,0,1
surfactant,0,0,0,1,0,1
surge capacity,0,1,0,0,0,1
surge index,1,0,0,0,0,1
surgery,0,0,0,1,0,1
"surgery: dynamic hip screw, hemiarthroplasty, hip replacement, intramedullary nail",0,1,0,0,0,1
surgical facial mask,0,1,0,0,0,1
surgical mask,0,0,0,1,0,1
surgical procedure for cancer,0,0,0,1,0,1
surgical procedures performed under general anesthesia,0,1,0,0,0,1
survey/questionnaire,1,0,0,0,0,1
surveys/questionnaires,0,1,0,0,0,1
susceptibility to infection,0,0,0,1,0,1
suspension,0,0,0,1,0,1
suspension/maintenance of angiotensin receptor blockers/angiotensin-converting enzyme inhibitors,0,0,0,1,0,1
swallowing evaluation with the eat-10,0,0,0,1,0,1
swallowing evaluation with the eat-10/the volume-viscosity swallowing test (v-vst),0,0,0,1,0,1
sweat samples (covidog ancillary study),0,0,0,1,0,1
symbicort,0,0,0,1,0,1
symptom,0,1,0,0,0,1
symptom survey,0,0,0,1,0,1
symptom/exposure surveys,0,1,0,0,0,1
symptomatic drugs,0,0,0,1,0,1
symptomatic treatment,1,0,0,0,0,1
symptomatic treatment (paracetamol,0,0,0,1,0,1
symptomatic treatment (paracetamol),0,0,0,1,0,1
symptomatic treatment (paracetamol/best symptomatic treatment based on doctor recommendations),0,0,0,1,0,1
"symptomatology, treatment. daily activities",0,0,0,1,0,1
symptoms,0,0,0,1,0,1
synthetic neutralising antibodies,0,0,0,1,0,1
systemic,0,0,0,1,0,1
t-cell receptor,0,0,0,1,0,1
t-detectâ„¢ sars-cov-2 assay,0,1,0,0,0,1
t cell derived exosom,1,0,0,0,0,1
t memory cells,0,0,0,1,0,1
t memory cells/nk cells,0,0,0,1,0,1
t3 solution,0,0,0,1,0,1
tablets,0,0,1,0,0,1
tafenoquine oral tablet,0,0,0,1,0,1
tailored best practices,0,0,0,1,0,1
tailored recommendations,0,0,0,1,0,1
tak-919,0,0,0,1,0,1
taking biological samples,0,0,0,1,0,1
tape-software,0,0,0,1,0,1
targeted message,0,0,0,1,0,1
taste/olfactory function evaluation,0,1,0,0,0,1
tavr,1,0,0,0,0,1
tavr/savr,1,0,0,0,0,1
tazobactam,0,0,0,1,0,1
tcc-covid mhealth,0,0,0,1,0,1
tcm,0,1,0,0,0,1
td139,0,0,0,1,0,1
tears swab,0,1,0,0,0,1
technology based social interactions,0,0,1,0,0,1
tele-delivered psychological intervention,0,0,0,1,0,1
tele-interventions related to diabetes management,0,1,0,0,0,1
tele-interventions related to diabetes management/mental well-being,0,1,0,0,0,1
teleconsultation,1,0,0,0,0,1
teleconsultation either by phone,0,1,0,0,0,1
teleconsultation either by phone/by computer consultation,0,1,0,0,0,1
telegeriatric intervention,0,1,0,0,0,1
telehealth monitoring,0,0,0,1,0,1
telehealth/counselling,1,0,0,0,0,1
telemedicine visit,0,0,0,1,0,1
telephone consult,0,0,0,1,0,1
telephone follow-up,1,0,0,0,0,1
telephone interview,1,0,0,0,0,1
telepsychoeducation,0,0,1,0,0,1
telepsychoeducation with personalized videos,0,0,1,0,0,1
telepsychoeducation without personalized videos,0,0,1,0,0,1
telesimulation,0,0,0,1,0,1
telmisartan 40mg oral tablet,0,0,0,1,0,1
tem-tpa,0,1,0,0,0,1
tenecteplase,0,0,0,1,0,1
tenofovir,0,0,0,1,0,1
tenofovir disoproxil/emtricitabine,0,0,0,1,0,1
tenofovir disoproxyl fumarate 300 mg,0,0,0,1,0,1
tenofovir disoproxyl fumarate 300 mg oral tablet,0,0,0,1,0,1
tenofovir disoproxyl fumarate 300 mg/emtricitabine 200 mg oral tablet,0,0,0,1,0,1
tensile strength,0,1,0,0,0,1
test,0,0,0,1,0,1
test group: experimental - uvc therapy applied,1,0,0,0,0,1
test rt-pcr,0,1,0,0,0,1
tested for sars-cov-2 (regardless of the result),0,0,0,1,0,1
testing,0,0,0,1,0,1
testing for sars-cov-2,1,0,0,0,0,1
testing sensitivity for sars-cov-2 virus in symptomatic individuals,0,1,0,0,0,1
testis pathology samples,0,0,0,1,0,1
testnpass,0,0,0,1,0,1
tetracycline hydrochloride 3%,0,0,0,1,0,1
tetrandrine,0,0,1,0,0,1
text material for psychoeducation,0,0,0,1,0,1
text material for psychoeducation/audio for relaxation techniques,0,0,0,1,0,1
"the demographic, clinical, laboratory,",0,0,0,1,0,1
"the demographic, clinical, laboratory,/instrumental data",0,0,0,1,0,1
the drugs used before,0,0,0,1,0,1
"the drugs used before/during the pandemic, the patient's job status, physical activity conditions, pain status",0,0,0,1,0,1
the management of severe covid-19 cases,1,0,0,0,0,1
the placenta,0,0,0,1,0,1
the psychosocial effects of covid-19 pandemic on dental professionals,0,1,0,0,0,1
the use of the mentalplusâ® digital game for assessment,0,0,0,1,0,1
the use of the mentalplusâ® digital game for assessment/rehabilitation of cognitive function after remission of the symptoms of covid-19,0,0,0,1,0,1
therapeutic exercise,0,0,1,0,0,1
therapeutic exercise/education,0,0,1,0,0,1
theraputic heparin,0,0,0,1,0,1
therapy intervention,0,1,0,0,0,1
there is no intervention in this study,0,0,0,1,0,1
thoracic computed tomography scan,0,0,1,0,0,1
thoracic ct,0,0,0,1,0,1
thoracic ct-scan,0,0,0,1,0,1
thoracic lung ultrasound,0,0,0,1,0,1
thorax ct,0,0,0,1,0,1
thoraxic computed tomography,0,0,0,1,0,1
three dose regimen,0,0,0,1,0,1
"three doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",0,0,0,1,0,1
"three doses of high-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 14, 28",1,0,0,0,0,1
"three doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14, 28",0,0,0,1,0,1
"three doses of placebo at the schedule of day 0, 14, 28 #high-dose group#",0,0,0,1,0,1
"three doses of placebo at the schedule of day 0, 14, 28 #middle-dose group#",0,0,0,1,0,1
"three doses of placebo at the schedule of day 0, 14, 28ï¼ˆhigh-dose groupï¼‰",1,0,0,0,0,1
throat,0,0,0,1,0,1
throat swab sample for measuring current infection with sars-cov-2,0,0,0,1,0,1
thrombin,1,0,0,0,0,1
thromboprofylaxis protocol,0,1,0,0,0,1
thymosin,0,0,0,1,0,1
thyroidectomy,0,1,0,0,0,1
ticeâ® bcg (for intravesical use) bcg live strain of the bcg (merck) vaccine,0,0,0,1,0,1
tigeraseâ®,0,1,0,0,0,1
tigeraseâ®/best available care,0,1,0,0,0,1
tirofiban,0,1,0,0,0,1
titanium blood test,0,0,0,1,0,1
tj003234,0,0,0,1,0,1
tlrs activation measurement,0,1,0,0,0,1
tm5614,0,0,0,1,0,1
tnkase,1,0,0,0,0,1
tociliuzumab,0,1,0,0,0,1
tocilizumab 20 mg/ml intravenous solution [actemra]_#1,0,0,0,1,0,1
tocilizumab 20 mg/ml intravenous solution [actemra]_#1 (2 doses),0,0,0,1,0,1
tof protocol,0,1,0,0,0,1
tomography angiography,0,1,0,0,0,1
tracheostomy,0,0,0,1,0,1
tracheostomy with aerosol box in covid-19 positive patients,0,1,0,0,0,1
tracheotomy,0,0,0,1,0,1
tradipitant,0,0,1,0,0,1
traditional proning arm,0,0,0,1,0,1
training clinicians in basic critical care,1,0,0,0,0,1
training clinicians in basic critical care/the management of severe covid-19 cases,1,0,0,0,0,1
"training for awareness, resilience,",0,1,0,0,0,1
"training for awareness, resilience,/action (tara)",0,1,0,0,0,1
training load,1,0,0,0,0,1
"training of youth, community health assistants",1,0,0,0,0,1
"training of youth, community health assistants/community health workers.",1,0,0,0,0,1
training session adressing information,0,0,0,1,0,1
training session adressing information/health literacy,0,0,0,1,0,1
tranexamic acid,0,0,0,1,0,1
trans sodium crocetinate,0,0,0,1,0,1
transcendental meditation,0,0,0,1,0,1
transcutaneous auricular vagus nerve stimulation,0,0,0,1,0,1
transfer package from ci therapy,0,0,0,1,0,1
transfusion of sars-cov-2 convalescent plasma.,0,0,0,1,0,1
transfusion of standard plasma.,0,0,0,1,0,1
transparent sheet,0,1,0,0,0,1
transplant patient,1,0,0,0,0,1
transpulmonary pressure measurements,0,0,0,1,0,1
transpulmonary thermodilution,0,0,0,1,0,1
transthoracic echocardiogram (tte),0,0,0,1,0,1
trauma-informed yoga video recording,0,0,0,1,0,1
trauma informed psychotherapy,0,0,0,1,0,1
trauma informed yoga,0,0,0,1,0,1
travelan otc,1,0,0,0,0,1
treamid,1,0,0,0,0,1
treated with hyperimmune plasma,0,0,0,1,0,1
treatment,0,1,0,0,0,1
treatment as usual vitamin d,0,0,0,1,0,1
treatment for covid-19,0,0,0,1,0,1
treatment group,0,0,0,1,0,1
treatment/prophylaxis,0,1,0,0,0,1
triazavirin (riamilovir),0,0,0,1,0,1
tricorâ® 145mg tablets,0,0,0,1,0,1
tridecactide,0,1,0,0,0,1
trier social stress test,0,0,0,1,0,1
trimetazidine,0,0,0,1,0,1
trimodulin,0,0,0,1,0,1
trimoxazole,0,0,0,1,0,1
trust in science message,0,1,0,0,0,1
trv027,0,0,0,1,0,1
tsvf,0,0,0,1,0,1
tuberculin,0,0,0,1,0,1
turkish physicians,0,1,0,0,0,1
two covid-19 vaccine candidate (tmv-083) administrations - high dose,0,0,0,1,0,1
two covid-19 vaccine candidate (tmv-083) administrations - low dose,0,0,0,1,0,1
two dose chadox1 ncov-19,0,0,0,1,0,1
two dose chadox1 ncov-19/covishield 0.25ml/0.5ml,0,0,0,1,0,1
two dose chadox1 ncov-19/covishield 0.5ml,0,0,0,1,0,1
two dose menacwy vaccine min. 4 weeks apart,0,0,0,1,0,1
two dose regimen,0,0,0,1,0,1
"two doses of commercial scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",0,0,0,1,0,1
"two doses of high-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",0,0,0,1,0,1
"two doses of high-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 28",1,0,0,0,0,1
"two doses of high dosage inactivated sars-cov-2 vaccine at the schedule of day 0,28",1,0,0,0,0,1
"two doses of middle-dose recombinant sars-cov-2 vaccine (cho cell) at the schedule of day 0, 14",0,0,0,1,0,1
"two doses of middle-dose recombinant sars-cov-2 vaccine (sf9 cell) at the schedule of day 0, 28",1,0,0,0,0,1
"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14",0,0,0,1,0,1
"two doses of pilot scale inactivated sars-cov-2 vaccine at the schedule of day 0,14 in elderly",0,0,0,1,0,1
"two doses of placebo at the schedule of day 0, 14 #high-dose group#",0,0,0,1,0,1
"two doses of placebo at the schedule of day 0, 14 #middle-dose group#",0,0,0,1,0,1
"two doses of placebo at the schedule of day 0, 28ï¼ˆhigh-dose groupï¼‰",1,0,0,0,0,1
"two doses of placebo at the schedule of day 0, 28ï¼ˆmiddle-dose groupï¼‰",1,0,0,0,0,1
txa127,0,0,0,1,0,1
type ii diabetes mellitus,0,0,0,1,0,1
type ii diabetes mellitus/covid-19 group (group ii),0,0,0,1,0,1
ub-612,0,0,0,1,0,1
ultra-micronized palmitoylethanolamide (mpea,0,0,0,1,0,1
ultra brief online mindfulness-based intervention,0,1,0,0,0,1
ultraprotective ventilation,0,0,0,1,0,1
umifenovir,0,0,1,0,0,1
"umpea, 300mg",0,0,0,1,0,1
unavailable covid test result - hypothetical scenario,0,1,0,0,0,1
unfractionated heparin iv,0,0,0,1,0,1
unfractionated heparin sc,0,0,0,1,0,1
uni911 inhalation,1,0,0,0,0,1
unified protocol for covid-19 parenting stress (up-covid),0,1,0,0,0,1
unsupervised physical activities,0,0,0,1,0,1
"urinary ngal, timp-2, igfbp7, il-6, viral load",0,0,0,1,0,1
"urinary ngal, timp-2, igfbp7, il-6, viral load/metabolomic",0,0,0,1,0,1
urine samples,0,0,0,1,0,1
usability,0,0,0,1,0,1
use,0,1,0,0,0,1
use of continuous positive airway pressure,0,1,0,0,0,1
use of facetime with child,0,0,0,1,0,1
use of facetime with child/parents during induction,0,0,0,1,0,1
use of high flow nasal cannula alone,0,1,0,0,0,1
use of non-invasive ventilation,0,1,0,0,0,1
use of social media during covid-19,0,1,0,0,0,1
"use of the pinpointiq solution (physiq, inc.)",0,0,1,0,0,1
use/exposure to disinfectants during the coronavirus pandemic,0,1,0,0,0,1
usual antibiotic treatment,0,0,0,1,0,1
usual care only,0,0,0,1,0,1
usual care positioning with no instructions,0,0,0,0,1,1
usual practice / symbicort rapihaler,0,0,0,1,0,1
utooth btc),0,0,0,1,0,1
uttr1147a,0,1,0,0,0,1
uv light treatment,0,1,0,0,0,1
v,0,0,0,1,0,1
v-sars,1,0,0,0,0,1
v hydrogen peroxide,0,0,0,1,0,1
v povidone-iodide,0,0,0,1,0,1
v) saline,1,0,0,0,0,1
v/q spect-ct,0,0,0,1,0,1
v590,1,0,0,0,0,1
v591,1,0,0,0,0,1
vaccinated with polio vaccine (ipv),0,0,0,1,0,1
vaccine coverage assessment,0,0,0,1,0,1
vaccine therapy,0,0,0,1,0,1
vaccine: recombinant new coronavirus vaccine (cho cell) low-dose group,1,0,0,0,0,1
vaccine: recombinant new coronavirus vaccine (cho cells) high-dose group,1,0,0,0,0,1
vadadustat,0,0,0,1,0,1
validation of the lamp assays,0,0,0,1,0,1
validation of the ngs method,0,0,0,1,0,1
validation of the poct antigen tests,0,0,0,1,0,1
vascular occlusion test,0,0,0,1,0,1
vb-201,0,0,0,1,0,1
vb-201 / standard of care,0,0,0,1,0,1
vcpm,0,0,0,1,0,1
vehicle,0,1,0,0,0,1
vehicle / heparin along with best supportive care,0,1,0,0,0,1
venipuncture in peripheral vein,0,0,0,1,0,1
venous blood was collected for biochemistry testing,0,1,0,0,0,1
venous blood was collected for biochemistry testing.,0,1,0,0,0,1
venous draw,0,0,0,1,0,1
venous draw/testing,0,0,0,1,0,1
ventaprost (inhaled epoprostenol delivered via a dedicated delivery system),0,0,0,1,0,1
verapamil,0,0,0,1,0,1
veru-111,1,0,0,0,0,1
vib7734,0,0,0,1,0,1
vibrolung,0,0,0,1,0,1
video-based intervention,0,0,0,1,0,1
video chat,1,0,0,0,0,1
video chat / basic feedback,1,0,0,0,0,1
video chat /personalized feedback,1,0,0,0,0,1
video dance classes,0,0,0,1,0,1
videofluoroscopic swallowing study (vfss),0,0,1,0,0,1
videofluoroscopy,0,0,0,1,0,1
vielight rx plus,0,0,0,1,0,1
views,0,0,0,1,0,1
viral sequence,0,0,0,1,0,1
virgin coconut oil (vco),0,0,0,1,0,1
virtual-care cognitive behavioural therapy,0,0,0,1,0,1
"virtual assistant first, then human coach",0,0,0,1,0,1
virtual care at home,0,0,0,1,0,1
virtual elm,1,0,0,0,0,1
virtual group exercise,0,0,0,1,0,1
virtual group intervention,0,1,0,0,0,1
virtual reality,0,0,0,1,0,1
virtual reality therapy first,1,0,0,0,0,1
viruxal oral,0,0,0,1,0,1
viruxal oral/nasal spray,0,0,0,1,0,1
visual analogue scale,0,0,0,1,0,1
visual prompts,0,1,0,0,0,1
vitamin b,0,0,0,1,0,1
vitamin c 500 mg oral tablet,0,0,0,1,0,1
vitamin c tablets,0,0,0,1,0,1
vitamin e,1,0,0,0,0,1
vitamins,0,0,0,1,0,1
vitis xtra forteâ©,0,1,0,0,0,1
vitros anti-sars-cov-2 igg test,0,0,1,0,0,1
viusid/asbrip,0,1,0,0,0,1
vla2001,1,0,0,0,0,1
voclosporin,0,0,0,1,0,1
voice symptom scale (voiss),0,0,0,1,0,1
volume rapid test,0,0,0,1,0,1
vr for psychoeducation,0,0,0,1,0,1
vr for psychoeducation/relaxation,0,0,0,1,0,1
vxa-cov2-1,1,0,0,0,0,1
walk test,0,0,0,1,0,1
ward css,0,0,0,1,0,1
water (e) mouth rinse with the solution provided,0,0,0,1,0,1
water without an elevated level of kelea,0,0,0,1,0,1
wearing surgical face mask sprayed with hypertonic saline,0,0,0,1,0,1
web-based redcap survey,0,0,0,1,0,1
web application users,0,0,0,1,0,1
web based questionnaire,0,0,1,0,0,1
weck-cel swab collection,0,0,1,0,0,1
weekly assessment,0,0,0,0,1,1
wharton's jelly derived mesenchymal stem cells.,0,0,0,1,0,1
white sender in acknowledgement,1,0,0,0,0,1
white sender in informational videos,1,0,0,0,0,1
who recommendations (waiting condition),0,0,0,1,0,1
whoqol-bref,0,0,0,1,0,1
withings scanwatch,0,0,0,1,0,1
without colchicine,0,1,0,0,0,1
woebot substance use disorder,0,1,0,0,0,1
wofb,0,0,0,1,0,1
written summary of rounds,0,0,0,1,0,1
x-ray,0,0,0,1,0,1
xav-19,0,0,0,1,0,1
xc221,0,1,0,0,0,1
xcel-umc-beta,0,0,0,1,0,1
yoga group,0,1,0,0,0,1
zanubrutinib,1,0,0,0,0,1
zaritt burden interview,0,1,0,0,0,1
zavegepant (bhv-3500),0,0,0,1,0,1
zidovudine,0,1,0,0,0,1
zilucoplan,0,0,0,1,0,1
zilucoplan placebo,0,0,0,1,0,1
zilucoplanâ®,1,0,0,0,0,1
zinc acetate,0,0,0,1,0,1
zinc citrate,0,0,0,1,0,1
zinc picolinate,0,0,0,1,0,1
zinc sulfate 220 mg,0,1,0,0,0,1
zithromax,0,0,0,1,0,1
zofin,0,0,0,1,0,1
